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ABSTRACT OF DISSERTATION 
 
 
SYNTHESIS AND CHARACTERIZATION OF POLYMERIC ANTIOXIDANT 
DELIVERY SYSTEMS 
Even though the role of oxidative stress in a variety of disease states is known, 
strategies to alleviate this oxidative stress by antioxidants have not been able to achieve 
clinical success. Particularly, treatment of oxidative stress by small molecule antioxidants 
has not received due attention because of the challenges associated with its delivery. 
Antioxidant polymers, where small molecule antioxidants are incorporated into the 
polymer backbone, are an emerging class of materials that can address some of these 
challenges.  
In this work, biodegradable polymers incorporating phenolic antioxidants in the 
polymer backbone were synthesized. Antioxidant polymers were then characterized for 
their in vitro degradation, antioxidant release and their effect on oxidative stress levels 
(redox state) in the cells. Trolox, a water-soluble analogue of vitamin E, was polymerized 
to synthesize poly(trolox ester) with 100% antioxidant content which undergoes 
biodegradation to release trolox. Nanoparticles of poly(trolox ester) were able to suppress 
oxidative stress injury induced by metal nanoparticles in an in vitro cell injury model.  
In another study, we polymerized polyphenolic antioxidants (e.g. curcumin, 
quercetin) using a modified non-free-radical polymerization poly(β-amino ester) 
chemistry. This synthesis scheme can be extended to all polyphenolic antioxidants and 
allows tuning of polymer degradation rate by choosing appropriate co-monomers from a 
large library of monomers available for β-amino ester chemistry. Poly(antioxidant β-
amino esters) (PABAE) were synthesized and characterized for their degradation, 
cytotoxicity and antioxidant activity. PABAE degradation products suppressed oxidative 
stress levels in the cells confirming antioxidant activity of degradation products. 
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Chapter 1. Introduction 
Oxidative stress is a pathological condition that has been implicated in variety of 
diseases including non-healing wounds, incompatibility of biomaterials and vascular 
diseases. During oxidative stress, reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) are produced in excess in relationship to the antioxidant defense 
mechanism leading to an imbalanced redox state. Methods proposed to alleviate oxidative 
stress include delivery of antioxidants, either small molecule antioxidants (e.g. vitamin E, 
vitamin C, glutathione, etc.) or antioxidant enzymes (e.g. SOD, catalase, etc.), that can 
eliminate oxidative species and restore normal redox state. Small molecule antioxidants 
are generally non-specific and scavenge a variety of ROS and RNS. Also, they are well 
tolerated, stable for long term storage, resistant to complex and/or aggressive formulation 
processing methods and relatively inexpensive. However, these small molecule 
scavengers typically reduce free radicals and other oxidizing species in stoichiometric 
ratios, being consumed in the process. Hence, large sustained doses are expected to be 
required in order to observe a significant clinical effect. Also, small molecule 
antioxidants can have a concentration dependant anti- or pro-oxidant effect, where 
delivery of small molecule antioxidants in excess (e.g. burst release from 
micro/nanocarriers) can induce an undesired pro-oxidant effect in host tissue. One of the 
major challenges in translating small molecule antioxidant therapy into clinical success is 
its delivery at the injury site at concentrations that can have a therapeutic effect. Carriers 
for small molecule antioxidants should be designed for delivery of significant amounts, 
but at a gradual and controlled rate. Antioxidant polymers, where small molecule 
antioxidants are incorporated in a biodegradable polymer backbone using covalent bonds, 
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allow to achieve both these goals by, 1.) enhancing the total mass of antioxidant in the 
carrier polymer and 2.) allowing chemical cleavage to control the release rate.  Many 
small molecule antioxidants have reactive groups like phenols, which can be easily 
functionalized and incorporated into polymers using polyester, polyanhydride or poly(β-
amino ester) chemistry. This approach provides that added benefit of protecting the labile 
center from premature oxidation. 
In this work, biodegradable polymers incorporating phenolic antioxidants in the 
polymer backbone were synthesized. Antioxidant polymers were then characterized for 
their in vitro degradation, antioxidant release and their effect on oxidative stress levels 
(redox state) in the cells. Trolox, a water-soluble analogue of vitamin E, was polymerized 
to synthesize poly(trolox ester) with 100% antioxidant content which undergoes 
biodegradation to release trolox. Nanoparticles of poly(trolox ester) were able to suppress 
oxidative stress injury induced by metal nanoparticles in an in vitro cell injury model. In 
another study, we polymerized polyphenolic antioxidants (e.g. curcumin, quercetin) using 
β-amino ester chemistry. Poly(β-amino esters) are known to be pH sensitive  and 
hydrolytically degradable. Also, a large library of monomers available for β-amino ester 
chemistry allows for careful tuning of the degradation rates. Poly(antioxidant β-amino 
esters) (PABAEs) were synthesized and characterized for their degradation and 
antioxidant activity. The effect of the degradation of PABAE on cytotoxicity and 
oxidative stress levels in the cells was also studied. Based on the encouraging results 
from these studies, we plan to study application of antioxidant polymers in, i.) targeted 
delivery of antioxidant polymer nanoparticles to injured vascular endothelium (e.g. 
ischemia/reperfusion injury) ii.) coating biomedical implants to suppress implant induced 
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inflammatory response which is marked by elevated oxidative stress in surrounding 
tissue, iii.) wound healing materials (e.g. dermal patches) for sustained delivery of 
antioxidants at wound site.  
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Chapter 2. Background 
Based on the book chapter and a review article published in : 
P.P. Wattamwar and T.D. Dziubla, “Modulation of Wound Healing 
Response Through Oxidation Active Materials”, To appear in : 
“Engineering Biomaterials For Regenerative Medicine: Novel 
Technologies for Clinical Applications”, S. Bhatia (Editor), Springer 
(Submitted) 
E. Hood, E. Simone, P.P. Wattamwar
 My contribution to this article is the review section titled “Polymer 
nanocarriers for delivery of antioxidants”. 
, T.D. Dziubla and V.R. 
Muzykantov, “Nanocarriers for vascular delivery of antioxidants”, Review 
article, Nanomedicine, 2011, 6(7), 1257-1272 
2.1 Introduction 
Oxidative stress is the pathophysiological condition which is characterized by the 
imbalance between an excess production of oxidants, called reactive oxygen species 
(ROS) and reactive nitrogen species (RNS), in relationship to the antioxidant defense 
mechanism’s ability to scavenge these oxidants. When produced in excess, ROS/RNS 
interact with and damage cellular and subcellular membranes, DNA, proteins, etc. and 
thereby impair normal functioning of cells. This process represents a primary and/or a 
secondary mechanism in inflammation and various disease states including 
neurodegenerative diseases, cardiovascular diseases and host tissue inflammatory 
response to biomaterial implants (Table 2-1). Methods that have been proposed to 
alleviate oxidative stress attempt to restore antioxidant defenses by the delivery of 
antioxidants that could eliminate oxidative species. As with many pharmacological 
approaches, a significant hurdle in the translation of antioxidant therapies into viable 
clinical treatment strategies lies in the inefficient and inadequate delivery of these agents 
to their intended site of action (e.g., the vascular endothelium, biomaterial implant site) 
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[1]. Indeed, mixed results from several decades of antioxidant research, including large 
scale clinical trials [2-4], have demonstrated that for antioxidant therapy to work, it must 
1.) scavenge the correct oxidant radicals, 2.) be targeted directly to the cells undergoing 
injury and 3.) remain functional for the duration of pathology [5-7]. While designing an 
antioxidant therapy for treatment, it is also necessary to understand the dynamic role of 
oxidative stress in disease processes and how different antioxidants interact with 
oxidative stress cycle in different settings. For example, treatment of an acute oxidative 
stress injury (e.g. ischemia-reperfusion) would require antioxidants to be delivered over a 
time frame of few hours to days. Whereas treatment of non-healing wound or suppression 
of a chronic biomaterial-induced oxidative stress, antioxidants need to be delivered over a 
time frame of a few weeks to months. Antioxidant polymers, where small molecule 
antioxidants are incorporated in polymer backbone using biodegradable covalent bonds, 
provide a promising platform for developing tunable antioxidant therapies for a variety of 
settings. Particularly, antioxidant polymers could make a significant impact in the areas 
of i.) wound healing, ii.) biocompatibility of materials and iii.) management of vascular 
oxidative stress. In the following sections, mechanism and role of oxidative stress in each 
of these disorders is discussed along with the challenges in delivery of antioxidants for 
treatment and how antioxidant polymers can overcome these limitations. 
2.2 Oxidative Stress 
While not fully elucidated, ROS/RNS play an important role in cell signaling 
directly via oxidation of cysteine residues on proteins [8] or indirectly by stimulating 
inflammatory signals (e.g. up-regulation of cytokines and cell adhesion molecules) [1] 
and mediate cellular responses like differentiation, proliferation, apoptosis and migration  
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 Table 2-1. Role of Oxidative Stress in Various Disease States. 
  SMC: Smooth muscle cell, CBP: Cardiopulmonary bypass. 
 
 
 
 
 
 
Disease or Syndrome ROS Sources References 
Atherosclerosis 
ROS-generating enzymes in vascular 
cells (EC, SMC). 
Activated leukocytes and 
macrophages. Oxidized LDL. 
[9-13] 
Myocardial infarction Cardiomyocytes. Activated leukocytes and platelets. [10, 11] 
Hypertension ROS-generating enzymes in vascular cells (EC, SMC). [13-15] 
Diabetes and Pancreatitis 
ROS-generating enzymes in vascular 
cells (EC, SMC). Activated 
leukocyte 
[13, 16] 
Acute lung injury, 
ARDS, sepsis, 
inflammation 
Activated leukocytes and 
macrophages. ROS-generating 
enzymes in vascular cells (EC, 
SMC). 
[17-20] 
Ischemia-reperfusion, 
transplantation, cardio-
pulmonary bypass 
(CBP),  Hypoxia 
ROS-generating enzymes in 
endothelial cells.  Activated 
leukocytes 
[10, 21-24] 
Hyperoxia 
High level of environmental oxygen 
and ROS. ROS-generating enzymes 
in endothelial cells. Activated 
macrophages and leukocytes 
[24, 25] 
Aging and other 
neurodegenerative 
diseases 
ROS-generating enzymes in 
endothelial cells. Activated 
macrophages and leukocytes 
[10, 26-28] 
Smoke inhalation, 
asbestoses 
Activated macrophages and 
leukocytes [29, 30] 
7 
 
[31-35]. When ROS/RNS production exceeds the cells antioxidant capacity, a 
degenerative pathological state known as oxidative stress occurs. For designing a 
successful antioxidant therapy to intervene the progression of oxidative stress, it is 
necessary to understand the source and location of ROS/RNS in the cell and their 
interactions with different antioxidants. The following sections review the mechanisms of 
ROS/RNS generation and the antioxidant defense mechanisms against oxidative stress.     
2.2.1 Mechanism and Chemistry 
Generation of various ROS/RNS by different reactions is highlighted in Figure 2-
1. Oxidative stress is often initiated by the generation of the superoxide anion (O2.-) 
during mitochondrial respiration or by enzymes like NADPH-oxidase (NADPHox), 
xanthine oxidase (XO), cyclooxygenases (COX) and P450 reductase. Upon activation, 
NADPHox converts molecular O2 to O2.-, which can then react with nitric oxide (NO.) to 
form peroxynitrite anion (ONOO-). NO. is a diffusible gaseous signaling molecule 
produced by the enzyme nitric oxide synthase (NOS) and affects vasorelaxation and 
platelet inhibition [36]. Preventing undesired oxidation by superoxide, superoxide 
dismutase (SOD) enzymatically converts O2.- to H2O2 (hydrogen peroxide). In the 
presence of the chloride anion (Cl-), myeloperoxidase (MPO) converts H2O2 into a very 
potent oxidant, hypochlorous acid (HOCl). H2O2 can also react with reduced transition 
metals like Fe2+ and Cu+ to form hydroxyl radicals (OH.) [37], which can react with 
polyunsaturated fatty acid (LH) to cause lipid peroxidation and form a carbon-centered 
lipid radical (L.). This lipid radical can then react with molecular oxygen to give a lipid 
peroxyl radical (LOO.). Lipid hydroperoxides (LOOH) are formed by reaction of LOO. 
with other lipids (LH). Lipid peroxidation continues when LOOH undergoes a fast 
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reaction with Fe2+ to form lipid alkoxyl radical (LO.) or a slow reaction with Fe3+ to form 
LOO. [38]. These radicals, in turn, oxidize more lipids and propagate the cycle. 
Compared to other molecules, ROS/RNS are relatively unstable, having very 
short half-lives on account of their ability to react with and oxidatively damage cellular 
proteins, DNA and lipids affecting normal functioning of cells/tissue. Even though 
ROS/RNS have a random destructive effect, in many pathological conditions that are 
subject to redox-sensitive pathways, production of ROS/RNS is tightly regulated with a 
specific downstream target [8, 20, 39]. Depending on pathological condition and the 
enzymes involved, ROS/RNS are generated within the cell, in cell lipid membrane or 
extracellularly. Extracellular milieu and outer leaflet of plasma membrane are the first 
target of extracellular ROS/RNS attack, where as intracellular ROS/RNS damage 
cytosolic proteins and the inner leaflet of the plasma membrane [40]. Location of the 
ROS/RNS generation should therefore be considered while designing an antioxidant 
therapy, and Figure 2-2 highlights generation of ROS/RNS at different subcellular 
locations. 
2.2.2 Antioxidants 
Antioxidants are the primary way cells and tissue are able to maintain a balance in 
the redox state (Figure 2-1) and can be classified into two major categories, small 
molecule oxidant scavengers (e.g. tocopherol, glutathione, quercetin, etc.) and 
antioxidant enzymes (e.g. SOD, catalase, etc.). Depending on their octanol/water 
partitioning coefficient, small molecule antioxidants can either localize in cellular 
cytoplasm or cellular and intracellular lipid membranes. For example, Vitamin E (T-OH), 
which can partition itself in lipid bilayer, scavenges LOO. to reduce it to lipid 
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hydroperoxide (LOOH) and in the process forms a Vitamin E radical (T-O.). There are 
some regenerative pathways (e.g., tocopherol/ascorbic acid redox cycling) [41] that exist 
within the cell that can help extend the useful life of a radical scavenger. However, these 
recycling loops depend strongly upon the cell’s own glutathione reducing pathway (e.g. 
Vitamin C/Ascorbic acid (AscH) or glutathione (GSH) react with T-O. to regenerate T-
OH). Water soluble antioxidants like vitamin C and GSH can also react with cytoplasmic 
ROS/RNS.  Small molecule antioxidants are generally non-specific, scavenge a variety of 
ROS and RNS and are consumed in the process. 
Antioxidant enzymes, on the other hand, are not consumed in reaction, allowing a 
single enzyme to react with millions of copies of radicals before becoming inactivated. 
For instance, catalase, which reduces H2O2 to water and oxygen, has a turnover number 
of 40 million hydrogen peroxide molecules degraded per second, allowing for even small 
delivered amounts to have profound cellular effects [42]. The enzyme glutathione 
peroxidase (GPx) can reduce lipid hydroperoxides and free H2O2 to corresponding 
alcohols and water respectively. The redox cycle of GPx requires an electron obtained 
from NADPH via GSH and glutathione reductase to catalyze the reduction of peroxides 
[43, 44]. Peroxiredoxins is another class of enzymes that use either thioredoxin or GSH 
or both as an electron donor to catalyze the reduction of H2O2, other hydroperoxides (e.g. 
LOOH) and ONOO- [45, 46]. While antioxidant enzymes have higher activity, they are 
typically limited to the scope of ROS which they can treat (e.g. SOD only decomposes 
O2.-). 
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Figure 2-1. Oxidants, Antioxidants and Antioxidant Enzymes  
Molecular oxygen is reduced to superoxide anion (O2.-) by NADPH-
oxidase (NADPHOX), xanthine oxidase (XO) and cyclooxygenases (COX). 
O2.- is dismutated by superoxide dismutase (SOD) to form hydrogen 
peroxide (H2O2) which then reacts with myeloperoxidase (MPO) and 
transient metals like Fe and Cu to form hypochlorous acid (HOCl) and 
hydroxyl radical (OH.) respectively. Antioxidant enzymes like catalase 
and glutathione peroxidase (GPx) reduces H2O2 into water and oxygen. 
OH. reacts with polyunsaturated fatty acid (LH) to cause lipid peroxidation 
and form carbon-centered lipid radical (L.) which further reacts with 
molecular oxygen to give lipid peroxyl radical (LOO.). Lipid peroxidation 
continues until antioxidants like Vitamin E (T-OH) scavenge lipid 
oxidants. Vitamin E (T-OH), which can partition itself in lipid bilayer, 
scavenges LOO. to reduce it to lipid hydroperoxide (LOOH) and in the 
process forms a Vitamin E radical (T-O.). Vitamin C/Ascorbic acid 
(AscH) or glutathione (GSH) react with T-O. to regenerate T-OH. Lipid 
peroxidation continues further where LOOH undergoes a fast reaction 
with Fe2+ to form lipid alkoxyl radical (LO.). LOOH can also react slowly 
with Fe3+ to form LOO..  
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Figure 2-2. A Simplified View of the Cellular Generation of ROS/RNS. 
Upon activation, membrane bound NADPHox and XO reduce molecular 
oxygen (O2) to generate superoxide anion (O2.-) at plasma membrane 
which can result in lipid peroxidation. O2.- is also generated in the 
mitochondria of cells as a result of electron leak from the respiratory chain 
[47]. In endothelial cells, endothelial NOS (eNOS) is primarily localized 
in caveolae (a cholesterol enriched microdomain in plasma membrane) 
and in Golgi apparatus [48]. Subcellular localization of tyrosine-nitrated 
proteins, product of protein oxidation by RNS, is determined by proximity 
to NOS and ROS generating enzymes [49]. In endothelial cells, tyrosine-
nitrated proteins were observed in mitochondria, endoplasmic reticulum, 
cytosol and nucleus, indicating the presence of RNS in these cellular 
compartments. Fat-soluble antioxidants like Vitamin E (T-OH) which 
partition themselves in plasma membrane and membranes of subcellular 
compartments provide protection against lipid peroxidation. Water-soluble 
antioxidants like Vitamin C and GSH scavenge radicals in the cytosolic 
compartment. Different isoforms of antioxidant enzyme SOD (SOD1, 
SOD2, SOD3) are located in cytosol, mitochondria and extracellular 
matrix respectively [50].    
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2.3 Biocompatibility of Implanted Materials 
 Surgical injury to vascular tissue during the implantation of a biomaterial (e.g. 
prostheses, drug delivery devices) brings the biomaterial in contact with blood and 
triggers wound healing process, which is classically broken down into four distinct yet 
overlapping phases - i.) blood protein adsorption on biomaterial surface, ii.) recruitment 
of inflammatory cells (neutrophils and monocytes) at the implant site, iii.) new tissue 
formation and iv.) foreign body reaction and fibrous capsule formation [51]. If any step 
becomes compromised (e.g. excessive inflammation), a chronic inflammatory response 
can be established, negatively impacting the biomaterial implantation. As a result, much 
attention has been given to biomaterial surface chemistry and topography that would 
dictate protein adsorption onto surface, effects of cytokines, signaling molecules, and 
growth factors on the wound response and using these to control biocompatibility of 
materials.  However, a parallel process of oxidative stress which also plays an important 
role in wound healing has been generating growing consideration as a means of tuning 
the wound healing process. It is the inflammation phase of the wound healing response, 
where excess generation of free radicals and other reactive species, which can result in 
loss of redox balance at the implant site resulting in a prolonged inflammation phase. 
This section reviews the role of oxidative stress in the inflammatory phase of wound 
healing and in the new tissue formation process. It also provides a summary of 
approaches that have been and can be used to intervene in the redox cycles as a way of 
additional control over wound healing, providing an additional tool by which to design 
antioxidant polymers as novel biomaterials. 
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2.3.1 Role of Oxidative Stress in Biocompatibility of Implanted Materials 
Wound healing response around an implant is very similar to the classical wound 
healing process that can be broken down into four main phases, a.) formation of blood 
clot and platelet plug, b.) inflammation, c.) new tissue formation and d.) tissue 
remodeling (Figure 2-3). The immediate first step response to a wound is to stop blood 
flow by initiating thrombosis. This fibrin clot serves as a temporary seal to the wound and 
provides a scaffold where other cells can migrate and proliferate. The hemostasis process 
is followed by inflammatory phase where the fibrin clot acts as a pool for variety of 
cytokines (e.g. interleukins, interferons, tumor necrosis factors) and growth factors (e.g. 
platelet-derived growth factor, transforming growth factor, etc.) that are released from 
degranulating activated platelets and the immune cells. Chemoattractants, which include 
growth factors released from the platelets and other cues like by-products of fibrin 
proteolysis or peptides cleaved from bacteria, result in the accumulation of inflammatory 
cells (neutrophils and monocytes) from the circulation. Also, cytokines and ROS 
upregulate expression of cell adhesion molecules (CAMs) (e.g. CD54) which recruit 
neutrophils and monocytes from circulation [40, 52].  
One of the major roles of neutrophils is to combat wound infection by eliminating 
the invading microorganisms (e.g. bacteria) through burst release of oxidative species 
[53]. Monocytes at the inflamed wound site differentiate into macrophages which 
phagocytose apoptotic neutrophils and other cellular/bacterial debris. Macrophages are 
responsible for the long term wound repair process not only by amplifying the 
inflammatory response but also by initiating the growth of new tissue. Macrophages and 
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other inflammatory cells also release cytokines and other growth factors that can activate 
fibroblasts and keratinocytes [54].  
One to two days after wounding, new tissue formation begins and is marked by 
migration and proliferation of various cells like endothelial cells, fibroblasts, 
keratinocytes and inflammatory cells. Keratinocytes (in case of dermal wounds) migrate 
over the injured dermis with concomitant angiogenesis to restore blood flow at the wound 
site. Fibroblasts along with macrophages replace the fibrin matrix with granulation tissue 
(called so due to appearance of several small capillaries) which also serves as a substrate 
for keratinocyte migration and proliferation. Macrophages activate fibroblasts to 
differentiate into myofibroblasts, which contract the wound gradually bringing edges of 
the wound closer together. Fibroblasts and myofibroblasts together also produce collagen 
rich extracellular matrix which forms bulk of the scar. The wound healing process is 
completed by a long phase of tissue remodeling that can last up to a year or more and is 
characterized by attenuation of all the activated processes [55]. Many of the recruited 
cells (endothelial, fibroblasts, macrophages) either undergo apoptosis or exit the wound 
leaving behind an acellular tissue mostly composed of collagen and some extracellular-
matrix proteins. Matrix metalloproteinases (e.g. MMP-1 and MMP-9) that are secreted by 
the cells replace type III collagen in the granulation tissue with type I collagen [56].  
ROS and RNS are involved in redox-sensitive cell signaling pathways that induce 
various responses like chemotaxis, proliferation, differentiation, etc. and  therefore 
oxidative stress (ROS and RNS) play a critical role in orchestration of each of these 
wound healing phases [57]. A better understanding of role and effect (both positive and  
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Figure 2-3. The Temporal Compositional Changes Expected in a “healthy” 
Wound Healing Response. 
 
Different cells are recruited at the wound site during the four phases of 
wound healing. ROS/RNS levels are elevated around day 1 and then 
gradually decrease to their basal level. 
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negative) of oxidative stress in each of the wound healing phases is necessary for optimal 
design of the therapeutic intervention strategy by using antioxidants. 
The following sections include detailed discussion of the role of ROS/RNS in the 
inflammatory phase and new-tissue formation phase of wound healing. Redox state plays 
an important role in the hemostasis process and is reviewed in detail by Gorlach and Sen 
et. al. [57, 58]. 
2.3.1.1 Inflammation 
ROS at the wound site play an important role in the recruitment/chemotaxis and 
the function of neutrophils and other immune cells. Chemotaxis is the migration of cells 
based on the concentration gradient cues. In a recent study with a zebrafish wound model, 
it has been shown that during the initial phase of wound detection, H2O2 gradient at low 
concentration (~ 0.5-50 µM) induces chemotaxis in leukocytes [59, 60]. Experiments 
have also shown that inhibition of NADPHox within the neutrophils affected their 
chemotactic migration, possibly by affecting ROS-based intracellular signaling [61].  
Elevated levels of thioredoxin, an important redox protein, in circulation inhibit 
lipopolysaccharide-stimulated (LPS) chemotaxis as well as the recruitment of leukocytes 
induced by murine chemokine KC/GROα, RANTES (regulated upon activation, normal 
T-cell expressed and secreted) and monocyte chemoattractant protein-1 (MCP-1) [62]. 
Immune response to a kill a pathogen is comprised of a respiratory burst by the immune 
cells. Neutrophils, phagocytes as well as other immune cells undergo respiratory burst, a 
rapid and non-mitochondrial conversion of O2 to battery of ROS and RNS by activation 
of membrane-bound NADPHox via chemoattractants or other inflammatory stimuli, to 
eliminate bacteria or other microorganisms that could cause an infection [63-65]. Any 
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defect in the NADPHox system, which is critical for the respiratory burst, results in the 
loss of resistance to infections [66, 67].  
Leukocytes are recruited to the wound site by a variety of chemoattractants, 
including fragmented extracellular matrix protein, tumor necrosis factor (TNF), 
transforming growth factor β (TGFβ), MCP-1, granulocyte colony-stimulating factor (G-
CSF), granulocyte/macrophage CSF (GM-CSF) and macrophage- inflammatory protein 
(MIP). Through ROS like H2O2 and O2.-, oxidative stress increases production of MIP-
1α, MIP-2, MCP-1, CSF-1 and other chemoattractants and is very critical in recruitment 
of immune cells at the wound site [68-73]. Oxidative stress also up-regulates the 
production of cytokines by cells. Expression of inflammatory cytokines expected at the 
wound site (e.g. TNFα, IL-8, IL-1β and IL-6) is stimulated by oxidative stress [74-76]. 
Effect of oxidative stress on expression and release of various inflammatory cytokines is 
summarized in Table 2-2.  
ROS and RNS are important in the functioning of immune cells. Exogenous H2O2 
induces calcium release from the intracellular compartments of neutrophils increasing 
their phagocytic activity [77]. H2O2 also modulates the respiratory burst of monocytes 
and neutrophils, where low concentrations of H2O2 stimulate O2.- production where as 
higher concentrations inhibit O2.- production [78-80]. Monocytes and macrophages 
protect themselves from the respiratory burst by H2O2 triggered increase in the uptake of 
GSH [81]. High mobility group box-1 (HMGB1), an endogenous pro-inflammatory 
cytokine, is passively released by necrotic cells or actively secreted by 
monocytes/macrophages to exogenous and endogenous stimuli such as TNF-α, IL-1, 
endotoxins and interferon-γ (IFN-γ) [82]. HMGB1 also mediates innate and adaptive 
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immune responses by promoting dendritic cell maturation [83]. Oxidative stress induces 
HMGB1 release, both actively and passively, from monocytes and macrophages in a 
mitogen-activated protein kinase (MAPK) and chromosome region maintenance 
(CRM1)-dependent mechanism. At non-toxic concentrations of H2O2 (< 0.125 mM), it 
stimulated interaction of HMGB1 with the nuclear export factor CRM1 where as at 
higher concentrations of 0.25 mM, H2O2 exhibited cell toxicity triggering active and 
passive release of HMGB1 [84]. Hypoxia induced HMGB1 release by hepatocytes during 
ischemia/repurfusion injury, is also regulated via toll-like receptor 4 (TLR4)-dependent 
ROS production and downstream calcium-mediated signaling [85].  
Neutrophils and monocytes are recruited from the circulation due to their 
receptivity to certain molecular signals that are expressed on the endothelial cells as a 
response to the wound. Expression of surface molecular signals on the endothelium alters 
as the wound healing progresses allowing for sequential recruitment of different classes 
of leukocytes at the wound site. Initially, selectin family of cell adhesion molecules 
expressed on the endothelium mediate tethering of leukocytes to the vessel wall, allowing 
for their rolling in the direction of the blood flow. The light adhesion to selectins is 
followed by tighter adhesions and arrest mediated by β2 subfamily of integrins. Attached 
leukocytes then follow directional cues from chemoattractants using integrins for traction 
and then crawl across the endothelium into extravascular space [52, 86]. Once the 
leukocytes leave the circulation and enter the extracellular matrix, they interact with 
matricellular proteins through the β1 subfamily of integrins. Both β1 and β2 integrins 
induce different signaling pathways in monocytes which are important for their  
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Table 2-2. ROS/RNS Play an Important Role in Inflammatory Phase by 
Affecting Expression and Release of Various Cytokines and 
Chemoattractants 
 
Cytokines and 
Chemoattractants Source Effect of ROS/RNS [Ref] 
MIP-1α Rat alveolar macrophages 
• H2O2 treatment induced MIP-1α 
mRNA expression  [69] 
MIP-2 
Rat alveolar 
macrophages, Rat 
lung epithelial cells 
• H2O2 increased MIP-2 mRNA 
expression 
• Quartz, TiO2, and crocidolite 
asbestos particles induced 
oxidative stress, resulting in 
increased MIP-2 expression  
[68, 72] 
MCP-1 
Human aortic 
smooth muscle 
cells, monocytes 
• PDGF stimulated O2.- release 
resulting in increased MCP-1 
mRNA expression 
• X/XO stimulated monocyte to 
produce MCP-1  
[70] 
CSF-1 Endothelial cells • TGF-β1 stimulated macrophage CSF via H2O2 based signalling  [73] 
TNF-α 
Human dendritic 
cells, Rat alveolar 
epithelial cells 
• H2O2 stimulated production of 
TNF-α  
• LPS induced glutathione depletion 
resulted in release of cytokines  
[74, 76] 
IL-8 
Human dendritic 
cells, Rat alveolar 
epithelial cells, 
Monocytes 
• H2O2 stimulated production of IL-8 
• LPS induced glutathione depletion 
resulted in release of cytokines 
• X/XO stimulated monocyte to 
produce IL-8  
[74-76] 
IL-1β Rat alveolar epithelial cells 
• LPS induced glutathione depletion 
resulted in release of cytokines  [76] 
IL-6 Rat alveolar epithelial cells 
• LPS induced glutathione depletion 
resulted in release of cytokines  [76] 
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functioning (migration and phagocytocis) and differentiation into the repairing 
macrophages [87].  
H2O2 promotes β2-integrin leukocyte function-associated antigen-1 (LFA-1)-
dependent attachment of neutrophils to cardiac myocytes and in presence of exogenous 
chemoattractants (e.g. c5a), there is a transition from LFA-1 to macrophage 1 antigen 
(Mac-1) dependent adhesion, resulting in prolonged attachment of neutrophils to 
myocytes [88, 89]. Also, neutrophils at early stages utilize the interaction of LFA-1 with 
inter-cellular adhesion molecule 1 (ICAM-1) to trigger H2O2 production without 
requiring chemotactic stimulation whereas the cytokine-induced respiratory burst of 
neutrophils is augmented by Mac-1-dependent adhesion of neutrophils [90-92]. This 
mechanism could result in additional recruitment of neutrophils by neutrophils whose 
ROS production is based on Mac-1-dependent adherence to myocytes. Cellular redox 
state affects expression of LFA-1 in myeloid lineage, where exogenous use of 
antioxidants like N-acetyl-L-cysteine and pyrrolidine dithiocarbamate suppressed 
expression of protein CD11a/LFA-1α [93]. Exposure of leukocytes to H2O2 and 
superoxide upregulated the expression of leukocyte adhesion molecules and promoted 
leukocyte-endothelial adhesion [94]. 
Mediators of inflammation (e.g. TNFα, IL-1 and IFN-γ), including ROS, 
modulate expression of endothelial surface adhesion molecules. Both endogenously and 
exogenously (as a result of attached leukocytes) released ROS from the endothelium 
upregulates expression of intercellular adhesion molecule-1 (ICAM-1, CD54), vascular 
cellular adhesion molecule-1 (VCAM-1) and P-selectin on surface of endothelial cells 
recruiting more leukocytes from the circulation [95-98]. Antioxidants N-acetyl-L-
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cysteine and pyrrolidine dithiocarbamate inhibited H2O2-induced and cytokine-induced 
expression of ICAM-1 respectively [99, 100]. 
Redox state of the cell also plays an important role in regulating chemokines and 
their receptors. Antioxidants pyrrolidine dithiocarbamate (PDTC), N-acetyl-L-cysteine 
(NAC) and 2-mercaptoethanol inhibited mRNA expression of chemokine receptors 
CCR2 (CC chemokine receptor-2), CCR5 and CXCR4 (CXC chemokine receptor-4) in 
human monocytes. Oxidative stress induced either by xanthine/xanthine oxidase, H2O2 or 
buthionine sulfoximine (a glutathione-depleting drug) counteracted the inhibitory effects 
of antioxidants and increased the expression of chemokine receptors [101, 102]. TNFα 
and bacterial lipopolysaccharide-mediated inhibition of CCR5 and CXCR4 mRNA 
expressions was opposed by generation of ROS (xanthine/xanthine oxidase), which 
increased both CCR5 and CXCR4 mRNA expressions and cell migration (3-fold) in 
response to MIP-1β [101]. Homocysteine-induced stimulation of CCR2 mRNA level is 
also mediated through superoxide formation [103]. Oxidative stress up-regulates the 
production of cytokines by cells. ROS stimulated synthesis of IL-8 and TNFα by 
dendritic cells [74]. A flow diagram of the relationship between oxidative stress and 
inflammation is provided in Figure 2-4. As shown, a failure to resolve oxidative stress 
can lead to chronic inflammation and, thereby, aberrant healing. 
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Figure 2-4. Initiation and Propagation of Oxidative Stress after Wounding.  
Failure to suppress excessive generation of ROS/RNS could result in pro-
longed inflammatory phase, finally resulting in a chronic non-healing 
wound. CAM: Cell adhesion molecules 
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2.3.1.2 New-tissue Formation 
2-10 days after the injury, wound closure and new-tissue formation starts which is 
characterized by migration of epithelial cells and, in the case of dermal wounds, 
keratinocytes. Any defect in the migration mechanism of the keratinocytes can result in a 
chronic non-healing wound [104]. Insulin-like growth factor-1 (IGF-1) facilitates cell 
spreading, stimulates membrane protrusion and migration of keratinocytes [105]. IGF-1-
induced signaling events are subject to redox control and ROS-induced oxidative stress 
can upregulate IGF-1 action by increasing expression of IGF-1 and IGF-1 receptor (IGF-
1R) [106-108]. 
Oxidative stress can induce proliferation and migration of smooth muscle cells 
and epithelial cells [109, 110]. Extracellular oxidative stress activates redox-sensitive 
pathways that increase Nox1-based NADPHox expression and vascular smooth muscle 
cell (VSMC) proliferation [111]. Matrix metalloproteinases (MMPs) are a class of 
enzymes that can degrade various components of cell-cell junction, cell-matrix contacts 
and extracellular matrix allowing different cells to migrate across the wound to promote 
re-epithelialization. Exogenous oxidative stress can activate MMP-2 and MMP-9 secreted 
from VSMCs [112]. Cells produce MMP-1 via Nox4 mediated and ROS-dependent 
pathway [113] and sustained exposure to ROS induced activation of pro-MMP-2 and 
increased cell motility [114]. Epidermal growth factor (EGF), transforming growth factor 
α (TGFα) and keratinocyte growth factor (KGF) are required for the proliferation of 
epidermal cells behind the migrating front [115]. ROS are capable of triggering EGF and 
KGF-dependent signaling and can also induce TGFα in fibroblasts [57]. Fibroblast 
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proliferation results in a collagen-rich scar tissue (granulation tissue) along with the 
formation of new blood vessels for nutrients and oxygen supply.  
The importance of ROS in angiogenesis and tissue vascularization can be inferred 
from the study by Roy et. al. where decomposition of H2O2 by adenoviral gene transfer of 
catalase resulted in impaired wound tissue vascularization [116]. Also, Nox1 induced 
molecular markers of angiogenesis [e.g. vascular endothelial growth factor (VEGF)] were 
eliminated after co-expression of Nox1 and catalase, indicating that H2O2 plays an 
important role in the angiogenic switch [117]. Oxidants not only induce VEGF 
expression but play a central role in VEGF signaling and is discussed in detail by Sen and 
Roy [57]. Several small molecule antioxidants like GSH, vitamin C, vitamin E and 
polyphenols (quercetin, curcumin, resveratrol, etc.) have anti-angiogenic properties, 
which suggest a positive role for oxidants in tissue vascularization [57, 118]. 
As discussed in the above sections, cells use ROS for intracellular as well as 
intercellular cell-cell signaling and there by switch ON/OFF different responses in a 
timely manner to orchestrate wound healing. Two sources of ROS production at the 
wound site are i.) respiratory burst by immune cells and ii.) ROS producing Nox/Duox 
family of enzymes (e.g. NADPHox, NOS, SOD) that are also expressed in other cells like 
endothelial cells, fibroblasts, keratinocytes. ROS levels at the wound site are attenuated 
by small molecule antioxidant scavengers and antioxidant enzymes and the following 
section explains their role in wound healing mechanisms. 
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2.3.2 Role of Antioxidants in Wound Healing 
2.3.2.1 Role of Small Molecule Antioxidants in Wound Healing 
The importance of small molecule antioxidant scavengers in the wound healing 
process is evident from the findings that the levels of antioxidants decrease post-injury 
and their sustained deficiency results in an impaired or chronic wound. Small molecule 
antioxidants like glutathione, vitamin C, vitamin E (tocopherol) and polyphenols (e.g. 
catechins, flavanoids, etc.) regulate the redox state at wound sites by eliminating free 
radicals. Table 2-3 provides a summary of effect of small molecule antioxidants on 
wound healing outcomes and their mechanism of action. Kamencic et. al. showed that 
oxidative stress caused after spinal cord injury resulted in reduced GSH levels. Post-
injury administration of L-2-oxothiazolidine-4-carboxylate (OTC), a compound used to 
increase intracellular cysteine level required for GSH synthesis, elevated previously 
reduced GSH levels allowing tissue preservation in spinal cord [119]. Analysis of the 
antioxidant status of a self-healing cutaneous wound at different times after wounding 
demonstrated that the levels of small molecule antioxidants (GSH, vitamin C & E) in 
injured tissue decreased by 60-70% as compared to normal skin and only GSH levels 
were recovered completely 14 days post-wounding [120]. The same group found that 
glutathione and vitamin E levels in wound tissue of aged rats were lower as compared to 
young rats, which could explain the delayed wound healing observed in the aged rats. In 
streptozotocin-induced diabetic rats, the 7-day wound tissue had lower levels of GSH (in 
contrast to elevated levels of vitamin E) which indicates that reduced levels of GSH could 
be responsible for delayed wound healing [121]. 
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Among diabetic patients with foot ulcers, the wound edge tissue as compared to control 
tissue had lower levels of GSH and cysteine, whereas elevated levels of mixed protein 
disulfides. Lower GSH levels were found in wound tissues of diabetic mice as compared 
to non-diabetic mice [122]. Hydrocortisone-treated immunocompromised rats also 
showed reduced levels of GSH, vitamin C and E in both normal and wounded skin (2 
days post-wounding) as compared to immunocompetent rats. 7 days post-wounding, 
levels of vitamin C and E in wound tissue of immunocompromised were similar to that of 
immunocompetent rats, but GSH level remained depleted even after 2 weeks [123] When 
rats were depleted of GSH using L-buthionine-(S,R)-sulfoximine (BSO), an inhibitor of 
rate-limiting enzyme in biosynthesis of GSH (γ-glutamylcysteine synthetase), there was a 
reduction in wound bursting strength as compared to untreated animals [124]. The same 
group also demonstrated that GSH levels are significantly lower in ischemic skin flaps, 
but preconditioning enhances skin flap survival by increasing activity of glutathione 
reductase and maintaining GSH levels [125]. All these results considered together 
indicate that depletion of small molecule antioxidants disturb the redox state of the 
wound and result in an impaired healing response. Restoring the redox balance in the 
wounds by application/delivery of small molecule antioxidants would be a viable strategy 
to improve the healing response. 
Topical application of glutathione monoester (GME), a drug used to increase 
intracellular GSH content, using carboxymethylcellulose (CMC) vehicle in a diabetic 
mice wound model resulted in significantly faster healing [122, 126]. 
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Table 2-3 Role of Small Molecule Antioxidants in Wound Healing 
 
Small Molecule Antioxidants Administration Route Wound Healing Parameters Affected Mechanism [Ref] 
Glutathione 
Topical application of 
glutathione monoester, 
administration of OTC 
Faster healing Restoring cellular redox potential by suppressing oxidative stress [119, 122] 
Vitamin E Oral Faster wound closure Suppressed lipid peroxidation [127] 
Ascorbic acid (Vitamin C) Oral, Topical 
Increased proliferation of 
fibroblasts and improved 
collagen synthesis 
Allows normal collagen hydroxylation (of 
proline residues) and is required to reduce 
Fe3+ 
 
In human dermal fibroblasts, improved 
cell motility as a result of increased 
expression of uPA, hyaluronan-mediated 
motility receptor and IL-6 expression 
[128-131] 
Curcumin Topical 
Faster wound closure, increased 
migration of  fibroblasts and 
myofibroblasts resulting in 
higher collagen deposition 
Reduced lipid peroxidation 
 
Upregulation of  levels of TGF-β1 and 
uPA 
 
Anti-inflammatory properties - In 
cultured A549 cells, suppressed H2O2 and 
TNF-α induced release of NF-κβ, AP-1, 
IL-8 and increased GSH biosynthesis 
[132-134] 
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Dietary supplementation of diabetic rats with palm vitamin E (70% tocotrienols 
and 30% tocopherols) extract (PVE) and α-tocopherol in an excisional wound model 
showed that PVE was more effective at enhancing wound healing and inducing 
antioxidant enzyme levels in the wounds of diabetic rats as compared to α-tocopherol. 
However, both antioxidants were able to reduce lipid peroxidation in healing wounds, as 
measured by lower MDA levels [127]. The difference in the potencies of PVE and α-
tocopherol could be attributed to the higher percent tocotrienols content of PVE or 
preferential pharmacokinetic distribution of tocotrienols in skin. Orally administered 
tocotrienols have better distribution in skin (15% tocotrienols distributed in the skin as 
compared to 1% tocopherols) and in some conditions tocotrienols have been reported as 
more potent antioxidants against lipid peroxidation than tocopherols [135-137]. Although 
the reasons for impaired wound healing in diabetic mice are not completely understood, 
an altered VEGF mRNA expression as a result of lipid peroxidation is one of the 
characteristics of wound healing defect among diabetic mice. Inhibition of lipid 
peroxidation in diabetic mice by systemic treatment with raxofelast, a hydrophilic 
vitamin E-like inhibitor of lipid peroxidation, normalized VEGF mRNA expression and 
secretion resulting in improved wound healing and angiogenesis [138, 139]. This effect 
of raxofelast was not seen in non-diabetic mice [139].  
Curcumin (diferuloylmethane), a yellow pigment present in the Indian spice 
turmeric, is a polyphenolic antioxidant that also interacts with several cell signaling 
proteins and thereby exert its anti-cancer, anti-inflammatory, anti-angiogenic, etc. effects 
[140-142]. Enhancement of wound healing by curcumin has been demonstrated in several 
studies [132]. Topical application of curcumin in full thickness excision wound model 
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resulted in increased cellular proliferation and collagen synthesis at the wound site and 
making wound heal faster. Curcumin exerted antioxidant effect at the wound site by 
decreasing lipid peroxidation and topical treatment resulted in increased activity of 
antioxidant enzymes SOD, catalase and GPx [143]. Biopsies of curcumin-treated animal 
wounds showed increased migration of fibroblasts, myofibroblasts, macrophages, 
improved neovascularization and higher collagen deposition at wound site. 
Immunohistochemical, in situ hybridization and polymerase chain reaction analysis 
showed an increase in transforming growth factor-β1 (TGF-β1) levels and TGF-β1 
mRNA expression, indicating that curcumin-treatment induced endogenous production of 
TGF-β1 in the wound of both diabetic and non-diabetic mice [144, 145]. TGF-
β1stimulates fibroblast proliferation and enhances fibroblast production of collagen and 
fibronectin, thereby playing an important role in production of extracellular matrix [146]. 
TGF-β1 has also been suggested to induce epidermal keratinocytes to express integrins 
that facilitate the migratory component of re-epithelialization [147]. Madhyastha et. al. 
have observed curcumin-induced and JNK and p38 MAPK mediated upregulation of 
urokinase plasminogen activator (uPA) gene expression, and that uPA upregulation is 
important in promoting fibrinolysis, matrix remodeling and cell migration, two 
mechanisms that are vital for wound healing [133, 148]. Faster wound closure and 
enhanced collagen deposition in curcumin-treated wounds could be a result of curcumin-
induced TGF-β1 production and uPA upregulation. In cultured alveolar epithelial cells 
(A549), curcumin suppressed H2O2-induced and TNF-α-induced NF-κβ, activator 
protein-1 (AP-1) and IL-8 release, exerting its anti-inflammatory properties. In the same 
study, curcumin-treatment of A549 cells resulted in an increased GSH biosynthesis and 
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glutamylcysteine ligase catalytic subunit mRNA expression, suggesting that antioxidant 
properties of curcumin do not depend only on its free radical scavenging ability [134].    
Beneficial effects of vitamin C (ascorbic acid) on wound healing in humans was reported 
by Ringsdorf and Cheraskin [128]. Topical application of vitamin C in a incisional 
wound model resulted in faster wound healing marked by reduced number of 
macrophages, increased proliferation of fibroblasts and new vessels, and thicker and 
more organized collagen fibers in the wounds [129]. Intraperitoneal administration of 
vitamin C prior to γ-radiation resulted in elevated wound contraction in a dose-dependent 
manner and improved healing of the wounds after whole body exposure to γ-radiation 
[149]. Ascorbic acid can regulate the extra cellular matrix synthesis by inducing 
increased collagen synthesis in human dermal fibroblasts. Stimulatory effect of vitamin C 
on collagen production results from its action in allowing normal collagen hydroxylation 
and restoring efficient collagen secretion [130]. Enzymatic mechanism suggested for 
hydroxylation of collagen (proline residues) occurs through a reactive iron-oxygen 
complex (the ferryl ion) and that ascorbic acid is required to reduce Fe3+ formed during 
the reaction [150]. Long term treatment of human dermal fibroblasts with L-ascorbic acid 
2-phosphate (AA2P), a stable vitamin C derivative, resulted an increase in cell motility in 
context of wound healing. Microarray analysis showed that AA2P treatment increased the 
expression of uPA, upregulated the hyaluronan-mediated motility receptor which is 
required for fibroblast migration in the context of wound healing and IL-6, which also 
promotes cell motility and matrix remodeling during wound healing [131]. 
Studies with other small molecule antioxidants like quercetin, allopurinol, 
retinoids (e.g. vitamin A, tretinoin) and uric acid have shown enhanced wound healing 
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and improved collagen content at wound site indicating that scavenging free radicals has 
a beneficial effect on overall wound healing process [151-154]. 
2.3.2.2 Role of Antioxidant Enzymes in Wound Healing 
Table 2-4 provides a summary of effect of antioxidant enzymes on wound healing 
outcomes and their mechanism of action. 
2.3.2.2.1 SOD 
Importance of SOD in wound healing can be inferred from the finding that SOD1 
deficiency resulted in a delayed wound healing response [155]. Steiling et. al. have 
studied spatial and temporal expression of different antioxidant enzymes during 
cutaneous wound repair and found that SOD1 and SOD2 mRNA levels were upregulated 
during early phase of wound repair when the oxidative burst occurs. In situ hybridization 
and immunofluorescence data indicated that Cu/ZnSOD is expressed in basal cells of the 
hyperproliferative epithelium at wound edge and in the granulation tissue. SOD2 was 
expressed in both, basal as well as suprabasal cells of hyperproliferative epidermis [156].  
Contrary to this data, Shukla et. al. had reported reduced activity of SOD after cutaneous 
injury and that SOD activity was not recovered even after 14 days [120]. This 
inconsistency in the mRNA expression and enzyme activity reported in the two studies 
could be a result of loss of enzymatic activity of SOD at wound site due to oxidative 
environment at the wound site [157, 158]. 
Intravenous administration of SOD in an ischemic skin injury model resulted in a 
reduction in edema and increased the wound breaking strength and collagen synthesis at 
wound site [152]. Delayed healing in streptozotocin-induced type 1 diabetic mice was  
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Table 2-4 Role of Antioxidant Enzymes in Wound Healing 
Antioxidant Enzymes Administration Route Wound Healing Parameters Affected Mechanism [Ref] 
Catalase 
Overexpression of catalase 
by adenoviral gene 
delivery, topical 
application 
Impaired wound angiogenesis, 
closure and slowed tissue 
remodeling 
 
Improved dental pulp tissue healing 
in 
 
Low concentrations of H2O2 mediate 
wound angiogenesis by VEGF 
expression 
[116, 159] 
SOD 
Intravenous SOD and 
SOD mimetic, cutaneous 
gene therapy of MnSOD 
Reduced wound edema, increased 
collagen synthesis and new blood 
vessel formation 
Reduced hyperglycemia-induced ROS [152, 160, 161] 
Peroxiredoxin Transgenic over expression of Prdx6 
Enhancement of wound closure in aged 
mice and reduced number of apoptotic 
cells after UVA/UVB irradiation 
Prdx6 deficient endothelial and 
inflammatory cells are more 
susceptible to ROS treatment 
Prdx6 knockout mice showed severe 
hemorrhage in granulation tissue 
 
[162, 163] 
 33 
 
restored by a single regimen of cutaneous gene therapy of MnSOD, marked by reduced 
superoxide levels and increased cutaneous MnSOD and NOS activity [161]. The same 
group also demonstrated that poor wound healing in diabetic mice is a result of decreased 
MnSOD expression and activity in endothelial progenitor cells (EPCs), which normally 
assist angiogenesis at wound site. By restoring diabetic EPC function after ex vivo 
MnSOD gene transfer prior to their transplantation at the wound site resulted in an 
enhanced and accelerated wound healing. Enhanced wound healing effect was also 
observed by increasing the number of transplanted diabetic EPCs [164]. Also, transgenic 
diabetic mice that overexpress MnSOD or treatment of diabetic mice with SOD mimetic 
corrected post-ischemic defects in neovascularization, oxygen delivery, chemokine 
expression and normalized tissue survival [160]. These results taken together demonstrate 
that scavenging superoxide can correct impaired wound healing process. 
2.3.2.2.2 Catalase and Glutathione Peroxidase 
Catalase and GPx at the wound site keep a check on the levels of H2O2 generated 
by SOD from superoxide anion. Steiling et. al. showed that catalase and GPx were 
coexpressed along with SOD in the wound. Along with Cu/ZnSOD and MnSOD, only 
the levels of selenoenzymes GPx (SeGPx) mRNA were upregulated during early phase of 
wound repair where as catalase and phospholipid hydroperoxide GPx (PhGPx) mRNA 
levels did not alter after injury. Like SOD, catalase and GPx mRNA expressions were 
also prominent in the hyperproliferative endothelium but were found in lower levels in 
the granulation tissue. Similar expression pattern of SOD, catalase and GPx suggests that 
H2O2 produced by SOD is detoxified by catalase and GPx before it could react with 
transition metal ions to generate deleterious hydroxyl radicals [156]. However, Shukla et. 
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al. have shown that catalase activity in the healing wounds decreased during the first 
week post wounding and activity level of catalase was recovered to its original level at 2 
weeks post-wounding [120]. Again as mentioned above, the discrepancy in the mRNA 
expression of catalase and the activity of catalase could be a result of enzyme inactivation 
or translational failure to code protein to due to the oxidative environment at the wound 
site.  
Unexpectedly, catalase overexpression by adenoviral gene delivery impaired 
wound angiogenesis, closure and slowed tissue remodeling [116]. H2O2 by itself or H2O2 
generated by overexpression of SOD1 via gene transfer induces VEGF expression in 
wound related cells [165-167] and low concentration of H2O2 present at the wound was 
important, mediating angiogenesis by up-regulating VEGF expression. However, in a 
separate study by Alacam et. al., topical application of catalase as a pulp-capping agent 
improved long-term (after 90 days) dental pulp tissue healing in a canine injury model 
[159].    
2.3.2.2.3 Peroxiredoxins 
Kümin et. al. studied expression of peroxiredoxins post injury in a full-thickness 
excisional wound model and found enhanced expression of Prdx6 and moderate increase 
in expression of Prdx4 as compared to unaltered expression of Prdx1 and Prdx2 [168]. 
Levels of Prdx6 mRNA were highest at day 1 after injury, remained elevated till day 7 
and levels reduced back to normal skin level 14 days post wounding when the wound was 
completely healed [169]. Using an in situ hybridization technique, it was found that in 
vivo, Prdx6 mRNA was highly expressed by keratinocytes of the hyperproliferative 
epidermis of skin wounds, although other cells in the granulation tissue also expressed 
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Prdx6 mRNA [170]. Since wound healing response was associated with altered Prdx6 
levels as compared to other five peroxiredoxins, Kümin et. al. have studied effect of 
Prdx6 overexpression and underexpression on wound healing [162, 168]. Although Prdx6 
knockout mice develops normally, they were found to be more susceptible to oxidative 
stress injury induced by intraperitoneal injection of paraquat, suggesting that Prdx6 aides 
in the regulation of superoxide mediated oxidative stress. Also, macrophages from these 
Prdx6 knockout mice had lower survival rates against oxidative insult induced by H2O2, 
t-butyl hydroperoxide and paraquat [171]. Even though Prdx6 expression was 
predominant in the hyperproliferative epidermis of skin, cutaneous injury to the Prdx6 
knockout mice resulted in normal wound epithelialization indicating that other 
antioxidant enzymes in these cells can compensate for absence of Prdx6. However, 
severe hemorrhage in the granulation tissue of the knockout mice was observed and the 
extent of hemorrhage correlated with the oxidative damage to the granulation tissue as 
indicated by presence of oxidized proteins and nitrotyrosine positive cells. At the 
ultrastructural level in the wound tissue of Prdx6 knockout mice, endothelial cells 
appeared to be damaged and their rate of apoptosis was also enhanced. Increased 
susceptibility of cultured endothelial cells to oxidative stress after siRNA-mediated 
knock-down of Prdx6 confirmed sensitivity of endothelial cells to loss of Prdx6. Wound 
healing studies in the bone marrow chimeric mice indicate that Prdx6-deficient 
inflammatory and endothelial cells contribute to the hemorrhage observed in the 
granulation tissue. This study also revealed the ROS mediated cross-talk between 
hematopoietic cells and resident cells at the wound [168]. Overexpression of Prdx6 in 
transgenic mice did not affect their skin morphogenesis and homeostatis. Keratinocytes 
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cultured form Prdx6 overexpressing mice showed enhanced resistance to ultraviolet A 
(UVA) and menadione-induced oxidative damage. Upon skin injury to these transgenic 
mice, enhanced wound closure was observed in aged animals, suggesting that 
overexpression of Prdx6 protected the skin from age related accumulative oxidative 
damage which is responsible for poor wound healing in aged animals [162]. 
2.3.3 “Antioxidant Materials” for Wound Healing 
As described, antioxidants clearly play an important role in ROS mediated inter-
cellular and intra-cellular signaling and pro-healing effects of several antioxidants. 
However, sub-optimal delivery of antioxidants to the wound site has complicated their 
use as a regenerative medicine strategy. Antioxidants could be delivered at wound site via 
oral route (or dietary supplementation), intravenously or direct dermal application to the 
wound. Several studies have shown that oral administration of antioxidants has a 
beneficial effect on wound healing [127, 172]. However, unfavorable pharmacological 
distribution of these antioxidants means that large doses are required for the antioxidants 
to reach a therapeutic concentration at the wound site, and the wound healing effect if any 
would be slow. Large doses of antioxidants for prolonged period could also result in 
other side effects. Also, oral delivery of AOE has been at best marginally effective [173]. 
All these drawbacks make oral delivery a less attractive option for wound healing 
applications. Direct application of antioxidants on the wound (e.g. topical application) 
seems to be an easier and effective way of antioxidant delivery to the wound site. 
However, direct application of antioxidants is limited by, i.) rapid clearance, ii.) stability 
and iii.) choice of material used to deliver antioxidants. 
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Loading antioxidants into a synthetic scaffold, a film or a porous 3D network, that 
acts as a diffusion barrier could be used for slow and controlled release of antioxidants 
from the scaffolds. Full thickness dermal wounds in rats that were treated with curcumin 
and quercetin incorporated collagen films showed increased wound reduction and 
enhanced cell proliferation as compared to control and collagen treated animals [151, 
174]. Incorporation of curcumin in electrospun nanofiber mats of cellulose acetate and 
poly(ε-caprolactone) (PCL) resulted in a sustained release of curcumin over ~ 3 days 
[175, 176]. Fibroblasts cultured on curcumin-loaded PCL nanofibers showed resistance to 
H2O2 induced oxidative stress and mouse macrophages cultured on curcumin-loaded PCL 
nanofibers reduced LPS induced IL-6 expression, a marker of inflammation. In a 
streptozotocin-induced diabetic mice wound model, curcumin-loaded PCL nanofibers 
had a pro-wound healing effect as evidenced by increased rate of wound closure [175]. 
Hydrogels, three dimensional network of hydrophilic polymers, can be used for 
immobilizing antioxidant enzymes to prevent inactivation of enzymes otherwise caused 
by direct application. Study by Chiumiento et. al. where they loaded 
carboxymethylcellulose (CMC) hydrogels with SOD and treated the rat wounds with 
CMC-SOD found that CMC-SOD reduced the time necessary for wound healing. Also, 
CMC-SOD had a proliferative effect on primary human fibroblasts [177].  
Effectiveness of scaffold based antioxidant therapy would also depend on the 
biomaterial used for the synthesis of the scaffold, since in some settings biomaterials 
could themselves induce an inflammatory response from the host tissue [178]. This 
inflammatory response is often the result of local accumulation of the polymer 
degradation byproducts or leachouts, inducing cellular oxidative stress [179-182]. One of 
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the approaches to suppress biomaterial induced inflammatory response could be to 
conjugate small molecule antioxidants like ascorbic acid, vitamin E, GSH, gallic acid, 
catechin, etc. to the polymer (‘antioxidant polymers’) [183-186]. Conjugation of low 
molecular weight superoxide dismutase mimetic (SODm) to implanted biomedical 
materials like ultra-high molecular weight polyethylene (UHMWPE), poly(etherurethane 
urea) and tantalum metal suppressed both chronic and inflammatory responses to the 
implants as evident by fewer neutrophils (after 3 days), fewer foreign body giant cells 
(FBGCs) (after 28 days) and inhibition of fibrous capsule formation [187]. Also, 
incorporation of NAC in poly(methyl methacrylate) (PMMA) bone cement reduced 
cytotoxicity of PMMA by scavenging free radicals and increasing GSH levels in 
osteoblasts, resulting in increased bone formation with higher strength [188]. Antioxidant 
polymers could not only be used to improve biocompatibility, but could also serve as a 
means of delivering antioxidants at the wound site. Some of the above mentioned 
examples of antioxidant polymers [184, 186] are limited by low percentage of antioxidant 
content as compared to the bulk material. If designed appropriately by increasing their 
percent antioxidant content and controlling the degradation rate (rate of release of 
antioxidants), antioxidant polymers can be used effectively for antioxidant delivery at the 
wound site. 
2.4 Role of Oxidative Stress in Biocompatibility of Biodegradable Materials 
Over the decades, biocompatibility has evolved from simply meaning an inert 
material [189, 190], which does not induce any deleterious tissue response, to the 
William’s definition, “the ability of a biomaterial to perform its desired function without 
eliciting any undesired effect, but generating a beneficial cellular or tissue response” 
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[191]. This shift in definition has accompanied our ever increasing understanding of the 
biological response to materials, which depends on the physiochemical properties, 
including shape, surface chemistry and, for degradable materials, the rate of degradation 
and degradation products. The summation of these properties can result in responses 
varying from the chronic inflammatory foreign body giant cell response to fibrous 
encapsulation to complete tissue integration [192, 193].  
Recent studies have demonstrated that even materials, which are classically 
considered biocompatible and FDA approved (e.g., poly(lactic acid)), can induce a 
pathological response. For instance, the degradation products of poly(lactic acid) have 
been shown to induce the oxidative stress response [179, 193, 194]. Monomers like 
bisphenol-glycidyl-methacrylate and 2-hydroxy-ethyl methacrylate, which are commonly 
used additives in dental bonding agents and resin composites, induce ROS production in 
human dental pulp cells and pulp fibroblasts leading to pulpal inflammation [195-197]. 
Detection of biomaterial-induced ROS is currently being used to characterize the 
inflammatory host tissue response to the biomaterial, in both in vitro and in vivo models 
[198, 199]. It is believed that control over this oxidative stress is a logical means of 
tuning the biological response to materials, improving their apparent biocompatibility.  
2.5 Vascular Oxidative Stress 
Vascular oxidative stress has been implicated as a key mechanism in the 
pathogenesis of many disease states (Table 2-1) [200] and is characterized by a 
dysfunctional endothelium, which is a key target for antioxidant therapy. Oxidative stress 
in the endothelium can be initiated and/or propagated due to exposure of EC to pro-
oxidants circulating in blood (oxidants released by activated leukocytes and platelets or 
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oxidized low-density lipoproteins) [201], oxidants produced by cellular milieu 
(extracellular matrix, other vascular cells) or oxidants generated by endothelial cells 
themselves [200]. VOS results in endothelial production of oxidants and expression of 
various inflammatory cytokines, which then influence the expression of inflammatory 
signals such as cell adhesion molecules (CAM) like ICAM-1, VCAM-1, etc [12, 14] 
(discussed in detail in Section 2.3.1). These CAMs facilitate endothelial-leukocyte 
interactions which further damages endothelial cells (EC) by releasing more oxidants 
[200, 202]. Oxidative stress and inflammatory response thus operate in vicious cycle to 
damage endothelium and result in a diseased state. 
2.5.1  Challenges in Delivery of Antioxidants to Suppress Oxidative Stress 
Both, small molecule oxidant scavengers (e.g. tocopherol, glutathione, etc.) and 
antioxidant enzymes (e.g. SOD, catalase, etc.), have their own unique set of delivery 
challenges. Small molecule antioxidants are well tolerated, stable for long term storage, 
resistant to complex and/or aggressive formulation processing methods and relatively 
inexpensive. However, these small molecule scavengers typically reduce free radicals and 
other oxidizing species in stoichiometric ratios, being consumed in the process [203, 
204]. Hence, large sustained doses are expected to be required in order to observe a 
significant clinical effect. 
Besides their high potency, antioxidant enzymes are also highly selective, 
allowing for a more targeted approach to antioxidant therapy not possible with small 
molecule antioxidants. However, antioxidant enzymes are relatively fragile and 
expensive, limiting the set of conditions which can be used for their formulation [173]. 
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Further, they are prone to proteolytic and pH dependant inactivation, which can limit 
their therapeutic duration [205, 206]. 
2.5.2 Nanocarriers for Vascular Delivery of Antioxidants 
As mentioned in Section 2.1, the success of antioxidant therapy for treatment of 
vascular oxidative stress depends on sufficient delivery of antioxidants to the 
endothelium and the duration for which the delivered antioxidants stay active. While the 
exact requirements needed depend upon the disease state being considered, nanoscale 
drug carriers are a promising avenue for achieving these goals. The following section 
reviews some of the existing nanocarrier startegies for antioxidant delivery and then 
explains the need for antioxidant polymers as a novel strategy for treatment of vascular 
oxidative stress. 
2.5.2.1 Liposomes 
Liposomes, one of the first and most widely studied carrier for drug delivery 
applications, are membrane vesicles formulated using naturally derived phospholipids or 
synthetic amphiphiles. Amphiphiles when dispersed in aqueous medium, self-assemble in 
a spheroidal membrane type arrangement where the hydrophobic lipid part of the 
molecules associate with each other whereas the hydrophilic heads are exposed to the 
aqueous phase, resulting in entrapment of aqueous phase in the spherical core. Extrusion 
and sonication are the most commonly used methods for the formulation of liposomes in 
the size range of 50 nm to 10 µm or more. Size of liposomes formulated using extrusion 
is determined by the pore size of the polycarbonate filter used for extrusion.  
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Spherical aqueous core and the lipid membrane domain can be used for loading 
hydrophilic and hydrophobic drugs respectively. Drug loading in the liposomes is 
determined by the equilibrium partitioning of the drug inside and outside the liposome. 
Since partitioning decreases with increase in MW of drug, liposomes are more suited for 
encapsulating low molecular weight hydrophilic drugs into the aqueous compartment. 
Some of the water-soluble antioxidants that can be loaded into liposomes include 
glutathione, N-acetyl cysteine (NAC) and ascorbic acid (vitamin C). Intratracheal 
liposomal delivery of NAC provided more pulmonary protection in a 2-chloroethyl ethyl 
sufide (CEES) injury model as compared to free NAC[207]. As opposed to large 
hydrophilic capacity, liposomes have a relative low hydrophobic capacity (~ 10-20% for 
100 nm liposome) for drug loading.  Nonetheless, this can be used for loading 
hydrophobic antioxidants like α-tocopherol (vitamin E) [207-209], resveratrol [210], 
curcumin [211] and flavonoids (e.g. quercetin, catechin) [212]. Liposomes improve the 
bioavailability of such hydrophobic compounds. Loading of large hydrophilic enzymes 
into liposomes is rather difficult. Freeze/thaw, freeze drying, pH gradient and 
electrostatic attraction have been used to improve the loading of antioxidant enzymes into 
liposomes [213-216]. 
Several liposomal formulations of vitamin C, vitamin E and other small molecule 
antioxidants have been successfully used for dermal applications in the cosmetic industry 
[217, 218]. Liposomes have also been commercially used as delivery vehicles for various 
pharmaceutics [219-221]. However, their use for the delivery of antioxidants through 
intravenous route has been limited due to their poor mechanical stability, poor circulation 
half-life and their rapid clearance through reticuloendothelial system  (RES) [218, 222]. 
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2.5.2.2 Solid Lipid Nanoparticles 
Solid lipid nanoparticles (SLN) are another lipid based carrier like liposomes, 
only difference being the lipids used (triglycerides and waxes) that are solid at room and 
physiological temperature. SLN are formulated either using high pressure 
homogenization or emulsification techniques at elevated temperatures with/without 
surfactants [223, 224]. Lipids used for SLN formulation are naturally derived and are 
likely to be well tolerated. The large hydrophobic core of SLN makes them a suitable 
delivery vehicle for carrying high loads of hydrophobic small molecule antioxidants. 
Several lipophilic small molecule antioxidants like vitamin E, baicalin, retinol, quercetin, 
curcuminoids and resveratrol were successfully loaded into SLN [225-230]. However, the 
harsh formulations conditions (e.g. high temperature and high shear) of SLN are not 
suitable for loading antioxidant enzymes which may lose activity during formulation. 
2.5.2.3 Polymer Nanoparticles 
Biodegradable polymeric nanoparticles are a logical choice for delivery of 
antioxidant enzymes.  Through the encapsulation of enzymes within a diffusion limiting 
polymer shell, the enzyme can be protected from premature proteolytic inactivation. 
Further, through tuning of the substrate diffusion properties of the encapsulating material, 
it is possible to impact the selectivity of the loaded enzyme [231].  Finally, as the enzyme 
is functional in the loaded state, the duration of activity can be controlled through the 
degradation rate of the polymer, with release of drug presumably possessing only 
transient activity. 
Poly(lactic acid) (PLA), poly(lactic acid-co-glycolic acid) (PLGA) and poly(ε-
caprolactone) have been formulated into nano and microparticles for controlled release of 
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drugs [232, 233].  Amphiphilic di-block copolymers (e.g. PEG-PLA, PEG-PLGA) can 
provide native “stealth” properties to polymer nanoparticles as well sites for conjugating 
targeting moieties. Nanoparticles of amphiphilic polymers can be synthesized using 
solvent evaporation, polymer micellization or multiple emulsification steps [234-236]. 
However, not all formulation settings can be used to load enzymes.  For instance, single 
step solvent extraction techniques typically result in poor protein loading, as the 
hydrophobic particles exlude the hydrophilic protein. Further, the use of aqueous 
miscible solvents (e.g., acetone, ethanol, methanol), can result in enzyme inactivation. 
Using a unique temperature swing double emulsion methods, polymer nanoparticles were 
formulated to achieve active catalase loading [206, 237]. These carriers were able to 
prolong enzymatic activity in a proteolytic environment, with 25% of the loaded enzyme 
mass remaining stably active after 24hours incubation, compared to free enzyme which 
lost >90% activity within 1 hour.  This method was found to be amendable to a variety of 
enzymes. Interestingly, enzymes whose substrates were slowly diffusing through the 
polymer shell possessed no measurable activity following proteolytic incubation, 
suggesting the ability for the carrier to augment the observed specificity of the loaded 
enzyme [231].   
2.5.2.4 Polymersomes 
Polymersomes (or polymer vesicles), synthetic polymer based analogs of 
phospholipid liposomes, are another class of polymer nanocarriers, which are composed 
of polymer amphiphiles that self-assembled into bilayer like structures (e.g., PEG-PLA, 
PEG-PBD(poly butadiene), PEG-poly(propylene-sulfide)-PEG) [238, 239] (for detailed 
review, refer to [240]). Like liposomes, polymersomes have large internal aqueous 
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domain that can be used for loading hydrophilic drugs. Thicker membrane of 
polymersomes ( ~8 nm as compared to ~3 nm for liposomes) make them a more robust 
carrier that can resist membrane deforming forces which disrupt the liposomal membrane 
[238]. Also, owing to the higher PEGylation density of polymersome surface, 
polymersomes have a two-fold higher circulation life (20-30 hrs in rats) as compared to 
liposomes [241]. Polymersomes have been used to load significant amounts of 
hydrophilic and hydrophobic anticancer drugs into aqueous core and membrane 
respectively [242-244]. Polymersomes can be used for simultaneous loading of both 
water-soluble and water-insoluble small molecule antioxidants for a robust antioxidant 
therapy. However, more rigorous encapsulation conditions (e.g. high temperature, 
pressure) for polymersome formulation can result in loss of enzyme activity which make 
polymersomes a non-ideal candidate for loading antioxidant enzymes [5, 245].   
2.5.2.5 Polymer Nanocapsules 
Encapsulation of a single protein molecule in polymeric shells, called “single-
protein nanocapsules”, is one of the novel approaches applied for protein delivery [246]. 
In this approach, several proteins, including SOD, were covalently functionalized with 
vinyl groups followed by free radical polymerization in the presence of other diacrylate 
monomers which resulted in encapsulation of single protein molecules in a nanometer 
thick (~ 5 nm) polymer shell. Surface properties and degradation rates of polymer shells 
was controlled by choosing appropriate monomers. SOD nanocapsules prevented cell 
death in a in vitro paraquat injury model, suggesting that the polymer shells are 
permeable to the substrate molecules (e.g. O2.-) and protect the enzyme from proteolytic 
degradation [246].  
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Polymer nanocapsules having large aqueous cores synthesized from 
(allyloxy)12cucurbit[6]uril, a rigid disk-shaped molecule, is another potential approach 
for protein delivery[247]. Even though their applicability for delivery of antioxidants has 
not been studied, work done by Kim et al. on developing a polymer nanocapsule 
incorporating disulfide bridges that can degrade in a reducing environment could be very 
applicable for release of antioxidant enzymes triggered by reduced environment in the 
host cell [248]. 
2.5.4 “Antioxidant Polymers” for Vascular Delivery of Antioxidants 
As discussed above, for small molecule antioxidant therapy to be successful, large 
sustained doses at the injury site are required. However, small molecule antioxidants have 
a concentration dependant anti- or pro-oxidant effect, where delivery of small molecule 
antioxidants in excess (e.g. burst release from nanocarriers) can induce an undesired pro-
oxidant effect in host tissue [249-251]. Hence, nanocarriers for small molecule 
antioxidants should be designed for delivery of significant amounts, but at a gradual and 
controlled rate. 
This makes delivery of small molecule antioxidants challenging as most of the 
carriers can achieve a maximum loading of ~35% for small molecule drugs [252-254]. As 
a result, in order to achieve sufficient antioxidant levels, large carrier masses may be 
needed, which may induce unwanted immunogenicity. Further, the passive loading of 
free small molecule drugs into nanocarriers can often result in limited control of drug 
release profiles [255]. Incorporating small molecule antioxidants covalently in a 
biodegradable polymer backbone permits a mechanism to overcome both of these 
limitations, by 1) enhancing the total mass of drug in the nanocarrier and 2) allowing 
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chemical cleavage to control the release rate.  Many small molecule antioxidants have 
reactive groups like phenols and thiols, which can be easily functionalized and 
incorporated into polymers using polyester, polyanhydride or poly(β-amino ester) 
chemistry [256]. This approach provides that added benefit of protecting the labile center 
from premature oxidation. 
Several approaches have been pursued to covalently conjugate small molecule 
antioxidants to polymers and proteins. For instance, Vitamin E was conjugated to 
poly(acrylic acid) to synthesize a water-soluble carrier for vitamin E that suppressed 
oxidative stress in sperm cells in vitro [183]. Antioxidant polymers with glutathione, 
ascorbic acid, gallic acid and catechin conjugated to PEG, poly(methyl methacrylate) and 
gelatin have also been synthesized and shown to have antioxidant properties in vitro 
[184-186]. However, these antioxidant polymers are limited by their low relative mass of 
antioxidant compared to the bulk material. There is need for antioxidant polymers with 
high “% antioxidant loading” that can be formulated into nanoparticles allowing for 
vascular delivery of these antioxidants. 
2.6 Conclusion – Rationale for Antioxidant Polymers 
Oxidative stress plays a critical role in wound healing, biocompatibility of 
materials and other vascular diseases. Translation of small molecule antioxidant therapy 
for treatment of oxidative stress into clinical success depends on i.) delivery of 
antioxidants in significant amounts, ii.) gradual release of antioxidants (i.e. control over 
rate of release) and iii.) minimizing undesired immunogenicity from carrier/delivery 
agent. Antioxidant polymers, where small molecule antioxidants are incorporated into a 
biodegradable polymer backbone, is an emerging area of research which may have huge 
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impact in the field of biomaterials. As demonstrated, antioxidant polymers have potential 
to address some of the problems related to the treatment of non-healing wounds, 
improving biocompatibility of materials and treatment of vascular oxidative stress 
through controlled delivery of small molecule antioxidants. 
This dissertation describes synthesis, characterization and evaluation of 
antioxidant polymers to suppress oxidative stress. Taking advantage of polymer 
chemistry, phenolic antioxidants were polymerized into polyesters and poly(β-amino 
esters). In vitro degradation characteristics of synthesized antioxidant polymers and their 
ability to suppress oxidative stress injury in the cells were studied. Also, effect of 
antioxidant polymers on the redox state of the cells in absence of injury agent was 
characterized. 
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Chapter 3. Research Goals 
3.1 Introduction 
 In this dissertation, antioxidant polymers are developed which upon degradation 
release active antioxidant scavenger molecules. These polymers are formulated either 
into polymer nanoparticles or hydrogels to study their degradation characteristics, 
cytotoxicity and ability to suppress oxidative stress in in vitro cell culture models. By 
delivering small molecule antioxidants in a controlled manner, it may be possible to treat 
a variety of diseases where oxidative stress plays a critical role in the pathophysiology of 
the disease. The robustness of this proposed small molecule antioxidant therapy will 
depend on the tunability of antioxidant polymers to deliver various antioxidants at 
different rates, which often vary depending on the disease. 
3.2 Objectives and Significance  
 The overall hypothesis of this work is : 
Antioxidant polymers can be synthesized that upon biodegradation release active 
antioxidants which can then scavenge free radicals to protect cells/tissues from 
oxidative stress injury.  
In order to test this hypothesis, research was planned in three distinct stages, 
described in the following sections as specific aims, each to test a specific hypothesis.        
3.2.1 Specific Aim 1: Synthesis and characterization of poly(trolox ester) 
A. Synthesis of poly(trolox ester) and its characterization using Fourier 
Transformed Infrared Spectroscopy (FTIR), 1H and 13C Nuclear Magnetic 
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Resonance (NMR) Spectroscopy and Gel Permeation Chromatography 
(GPC).   
B.   Formulation of poly(trolox ester) nanoparticles with control over their 
size. 
C. Study in vitro degradation of poly(trolox ester) nanoparticles, determine 
antioxidant activity of degradation products and determine their 
cytotoxicity.  
3.2.1.1 Hypothesis #1  
Trolox can be polymerized into a poly(ester) form using carbodiimide based 
condensation reaction and degradation products of poly(trolox ester) will have 
antioxidant potential to scavenge free radicals without exerting any cytotoxic 
effects.  
3.2.1.2 Significance and Outcome 
 Experiments carried out to test this hypothesis are explained in Chapter 4. Using 
Steglich esterification reaction, poly(esters) of trolox with two different molecular 
weights, PTx-1000 and PTx-2500 were synthesized. FTIR and 13C NMR characterization 
confirmed successful esterification reaction to synthesize PTx-1000 and PTx-2500. GPC 
analysis was used to determine molecular weight of synthesized polymers. Single 
emulsion technique was employed to formulate polymer nanoparticles with controlled 
size. Poly(trolox ester) nanoparticle degrade very slowly by hydrolysis. However, they 
are susceptible to enzymatic degradation and degradation products have radical 
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scavenging ability as measured using a in vitro assay. Poly(trolox ester) nanoparticles had 
very little to no cytotoxicity up to a concentration of 1 mg/ml.   
3.2.2 Specific Aim 2: Investigate Effect of Poly(trolox ester) on Oxidative Stress in 
the Cells, Both in the Presence and Absence of Injury Agent  
A.  Study the protective effect of poly(trolox ester) nanoparticles against 
metal nanoparticle induced oxidative stress injury.   
B.   Study the concentration dependant effect of trolox and poly(trolox ester) 
nanoparticles on the redox state of the cells. 
C. Use protein oxidation as a marker of oxidative stress to determine effect of 
poly(trolox ester) nanoparticles on the redox state of the cells.  
3.2.2.1 Hypothesis #2 
Poly(trolox ester) nanoparticles suppress oxidative stress in the cells, both in 
presence and absence of oxidative injury, and can be used to modulate redox state 
of the cell.  
3.2.2.2 Significance and Outcome    
 Chapter 5 describes the experiments carried to test this hypothesis. DCF 
fluorescence was successfully used to monitor oxidative stress levels in the cells. 
Treatment with poly(trolox ester) nanoparticles protected cells from the metal 
nanoparticle induced oxidative stress injury. In the absence of injury, poly(trolox ester) 
nanoparticles suppressed background oxidative stress levels in the cells as measured by 
DCF fluorescence as well as by protein carbonyl measurements. Monitoring oxidative 
stress in the cells using DCF fluorescence revealed concentration dependant prooxidant 
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and antioxidant effect of trolox, whereas measurement of redox state using cellular 
protein oxidation products did not exhibit this effect of trolox. This emphasizes the 
importance of delivery route in modulating redox state of the cell using slow degrading 
poly(trolox ester) nanoparticles.  
3.2.3 Specific Aim 3: Develop a flexible polymer chemistry that could be extended 
to variety of antioxidants and could be tuned for their degradation rate. 
A. Apply non-free-radical polymerization poly(β-amino ester) chemistry to 
synthesize polyphenolic antioxidants based poly(antioxidant β-amino 
esters) (PABAE). 
B. Investigate degradation characteristics of PABAE and determine 
antioxidant activity of PABAE degradation products.  
C.  Investigate cytotoxicity of PABAE degradation products and their effect 
on cellular oxidative stress levels in absence and presence of injury. 
3.2.3.1 Hypothesis #3 
Polyphenolic antioxidants can be incorporated into PABAE hydrogel which 
undergo hydrolytic degradation and their degradation products have antioxidant 
activity capable of suppressing oxidative stress in the cells. 
3.2.3.2 Significance and Outcome 
 The non-free-radical polymerization poly(β-amino ester) chemistry described in 
Chapter 6 was successfully used to incorporate acrylate functionalized quercetin and 
curcumin into a PABAE network. This polymerization scheme can be extended to all 
polyphenolic antioxidants and allows tuning of the rate of polymer degradation by 
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appropriate choice of co-monomers and ratio of these co-monomers. Chapter 7 describes 
cytotoxicity of PABAE degradation products and their effect on oxidative stress levels in 
the cells which were similar to the effects of the corresponding free form antioxidants.  
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Chapter 4. Synthesis and Characterization of Poly(trolox ester) 
Based on the research article published in : 
P.P. Wattamwar
4.1  Introduction 
, Y. Mo, R. Wan, R. Palli, Q. Zhang and T.D. Dziubla, 
“Antioxidant Activity of Degradable Polymer Poly(trolox) to Suppress 
Oxidative Stress Injury in the Cells”, Advanced Functional Materials, 
2010, 20, 147-154. 
 While it is thought that degradable materials can evade long term compatibility 
issues through degradation, recent studies found that the local accumulation of acids 
(which are by-products of biodegradation) and monomer/oligomer leachouts, may trigger 
inflammatory response leading to further oxidative stress [179-181, 193-196]. Attempts 
have been made to attenuate biomaterial induced oxidative stress by synthesizing 
polymers (e.g. polyketals) that would result in neutral degradation products [257]. Studies 
have shown that the conjugation of antioxidant molecules to various polymers can 
suppress oxidative stress [188, 258, 259]. For example, vitamin E along with 
carbohydrate-targeting protein and solubility enhancers were conjugated to 
acrylate/methacrylate backbone to synthesize a water soluble antioxidant polymer. 
Cellular uptake of these polymers resulted in a slow release and accumulation of vitamin 
E over a period of 8 days [258]. Oligomers of glutathione and poly(ethylene glycol), 
where glutathione was linked to poly(ethylene glycol) (600 g/mol) using disulfide 
linkages, self-assembled to form aggregates (~300 nm) which protected cells from H2O2 
based oxidative stress injury [259]. In other examples, ascorbic acid and polyphenols 
were conjugated to gelatin and methacrylic acid to result in non-biodegradable polymers 
that had antioxidant functionality [184, 185]. However, these functional materials are 
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limited in their heterogeneity and low relative mass of antioxidant compared to the bulk 
material. Taking a cue from the pioneering work in anti-inflammatory polymers of 
aspirin [260], in this work, we synthesized a new biodegradable polymer, poly(trolox 
ester), having native antioxidant activity. Trolox, a synthetic and water soluble analogue 
of Vitamin E (Figure 4-1), released as degradation product of the polymer could 
theoretically attenuate the biomaterial oxidative stress by scavenging ROS like 
superoxide anion, hydroxyl radical and RNS like peroxynitrite [261-263].   
As an alternative to pendant conjugation strategies, trolox, a water-soluble analogue 
of vitamin E, was polymerized through a polycondensation reaction mediated by 
Stagelich esterification. As the condensation pairs used result in a zero length conjugation 
bond, the resulting biodegradable poly(trolox ester) possesses 100% antioxidant mass.  
Using a single step solvent extraction method, it is possible to formulate poly(trolox 
ester) into nanoparticles of sizes 100-250nm. We report here that the formulated polymer 
nanoparticles undergo enzymatic degradation resulting in degradation products that have 
ability to scavenge radicals and that these nanoparticles were found to have little to no 
cytotoxicity at concentrations up to 1mg/ml. 
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Figure 4-1. Chemical Structure of Vitamin E (top) and Trolox. 
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4.2  Materials and Methods 
4.2.1 Synthesis of PTx-1000 
 For PTx-1000, a carbodiimide and 4-(dimethylamino)pyridine (DMAP) based 
reaction was used (Figure 2) [264]. Molecular sieves (4 Å pore size) were added to 
dichloromethane (DCM) and stirred overnight under inert atmosphere to capture any 
water present in the solvent. Using line transfers, anhydrous DCM (60 ml per 1 g of 
trolox) was transferred to a reaction vessel loaded with trolox and DMAP (0.5 molar 
equivalent of trolox). Solution of trolox and DMAP in DCM was warmed till it became 
clear. In a separate vessel, N,N′-dicyclohexylcarbodiimide (DCC) was dissolved in 
anhydrous DCM at a stock concentration of 40 mg/ml. This DCC solution was added to 
the trolox/DMAP solution under continuous stirring until DCC was 10% in molar excess 
of trolox. The reaction mixture was stirred in the dark for 24 hrs under a continuous slow 
argon purge. After this reaction, the precipitated dicyclohexyl urea was removed by 
vacuum filtration. The filtrate was dried under vacuum using a roto-evaporator 
(Rotovapor R II, Buchi, Switzerland). The resultant yellowish powder was re-dissolved in 
acetone and subjected to ultrafiltration. Ultrafiltration was performed to remove 
unreacted compounds and catalyst from the polymer product using a solvent-resistant 
stirred cell with a 3 kDa MWCO Ultracel YM/PL ultrafiltration membrane (Millipore, 
USA). Acetone was evaporated from the retentate and the resultant solid polymer mass 
was subjected to vacuum overnight to remove residual solvent. PTx-1000 was stored 
under dark at room temperature. 
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Figure 4-2. Trolox Polymerization Scheme 
Trolox (1, n=1) undergoes an esterification reaction to form poly(trolox 
ester) (1). Carbodiimide (2)  reacts with the terminal carboxylic acid group 
of 1 to form an active intermediate O-acyl urea (3). Catalyst DMAP (5) 
then traps this intermediate and reacts with the phenolic group of 
trolox/poly(trolox ester) (1) to form an ester. This new product (1) has a 
carboxyl group that can repeat this process allowing for the growth of the 
polymer. Urea (6) is a by-product that precipitates out in reaction mixture 
where as N-acyl urea (4) is an undesired side-product formed by 
rearrangement of 3. It is theorized that the formation of 4 results in the 
terminal capping of this reactive end group and prevents further polymer 
chain growth. (This reaction mechanism is adapted from Wiener and 
Gilon [264].) 
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4.2.2 Synthesis of 4-(Dimethylamino)pyridinium 4-toluenesulfonate (DPTS) 
 DPTS was synthesized following the procedure as described in detail by Moore 
and Stupp [265]. Dry p-toluenesulfonic acid (PTSA) was obtained by subjecting a 
solution of PTSA in toluene to azeotropic distillation using a Dean-Stark trap. Separately, 
an equimolar amount of DMAP was dissolved in toluene and then added to the dry 
solution of PTSA in benzene under continuous stirring. The resulting suspension of 
DPTS was stirred for a while and then cooled to room temperature. DPTS suspension in 
toluene was vacuum filtered and was recovered as solid powder. DPTS was further 
purified by dissolving it in boiling DCM at saturation conditions. DCM solution was 
stored overnight at -20ºC. The resultant needle shaped white crystals were recovered by 
vacuum filtration. Using differential scanning calorimetry, melting point of DPTS (MW 
= 294 g mol-1) was found to be 176 0C, which is similar to previously reported melting 
point of 165 0C [265]. 
4.2.3 Synthesis of PTx-2500 
A carbodiimide-DPTS based reaction was employed for PTx-2500 synthesis 
[265]. DCM was dried overnight over calcium hydride. Anhydrous DCM (27 ml per 1 g 
of trolox) was then distilled into a two neck round bottom flask loaded with equimolar 
amounts of trolox and DPTS. Reaction mixture was turbid to begin with since trolox 
concentration was above its saturation concentration. N,N’-diisopropylcarbodiimide 
(DIC) (1.5 molar equivalents of trolox) was weighed and added as a neat reagent using a 
syringe. The reaction mixture was stirred under dark and inert conditions for 24 hrs. Inert 
conditions were maintained by purging argon through reaction vessel. After 24 hrs, DCM 
was evaporated off from reaction mixture using a roto-evaporator and solid mass was 
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dissolved in acetone. The insoluble diisopropyl urea was removed by vacuum filtration 
and the filtrate was subjected to ultrafiltration as described in PTx-1000 synthesis. PTx-
2500 was obtained as yellowish dry powder and was stored in the dark at room 
temperature. 
4.2.4 Characterization of Synthesized Polymers 
 Synthesized polymers were characterized using Fourier Transformed Infrared 
(FTIR) spectroscopy, 13C Nuclear Magnetic Resonance (NMR) spectroscopy and Gel 
Permeation Chromatography (GPC). FTIR measurements were performed on a Digilab 
Stingray system consisting of a FTIR 7000e stepscan spectrometer (Varian Inc.). 13C 
NMR spectra were obtained using a Varian Gemini 200 MHz NMR spectrometer. A 
Shimadzu Prominence LC-20 AB HPLC system installed with a waters 2410 refractive 
index detector was used to calculate molecular weight using GPC. 300 x 7.5 mm PLgel 3 
µm mixed-E column (Polymer Laboratories), 300 x 7.8 mm Waters Styragel HR-1 and 
HR-2 colums were used in series for separation. Polystyrene standards (Polymer 
Laboratories) in the molecular weight range of 20,000 to 500 Da were used (with 
tetrahydrofuran as eluent) to develop a linear range of calibration for molecular weight 
determination. 
4.2.5 Nanoparticle Formulation and Characterization 
 PTx-1000 and PTx-2500 are both insoluble in water, allowing them to be 
processed as nanoparticles. A single emulsion procedure was employed for nanoparticle 
formulation. Polymer was dissolved in acetone at a known concentration. This acetone 
solution was then added to a pluronic F-68 solution in phosphate buffered saline (PBS) 
while vortexing at 1400 rpm. In all the formulations, the final concentration of acetone in 
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the surfactant solution was 10 % v/v. Concentration of surfactant solution and 
concentration of polymer in acetone were varied to control the size of nanoparticles. The 
particle solution was left open under stirring conditions overnight to let the acetone 
evaporate off. Formulated nanoparticles were subjected to ultrafiltration to remove excess 
surfactant from nanoparticle suspension. Ultrafiltration was performed using a 100 kDa 
MWCO Ultracel YM/PL membrane in a stirred cell. Particle size was measured before 
and after the ultrafiltration using dynamic light scattering on a Malvern Zetasizer Nano 
(Westborough, MA). Nanoparticles free of excess surfactant were used for all the further 
studies. 
4.2.6 In Vitro Degradation of Poly(trolox ester) 
Poly(trolox ester) nanoparticles were diluted to a final concentration of 1 mg/ml 
in PBS at pH of 7.4 with and without the enzyme carbonic anhydrase (CA). CA was 
dissolved in PBS at a concentration of 2 mg/ml and the nanoparticle suspension was 
incubated in a shaker bath at 37 0C. 150 µL of aliquots were removed at different time 
points and were immediately analyzed for their antioxidant activity and size.  
4.2.7 In Vitro Assay for Measurement of Antioxidant Activity 
Antioxidant activity of samples from degradation studies was measured using a 
2’,7’-dichlorofluorescein (DCF) based fluorescent assay. An azo initiator 2,2’-azo-bis(2-
aminopropane)-HCl (AAPH) that undergoes thermal degradation was used to mimic the 
peroxyl radical formation in vivo. Procedure described by Aldini et. al. was followed for 
hydrolysis of 2’,7’-dichlorodihydrofluorescein diacetate (DCF-DA) [266]. In brief, 500 
µL of 1 mM DCF-DA stock solution in ethanol was added to 2 ml of 0.01 N NaOH 
solution and stirred for 20 min under darkness. Solution was then neutralized by adding 2 
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ml of 0.01 N HCl solution. Hydrolysis of DCF-DA results in 2’,7’-
dichlorodihydrofluorescein (DCFH) which is then diluted in PBS to a final concentration 
of 10 or 20 µM. The diluted DCFH solution was stored in ice under darkness and was 
used for further measurements within 4 hrs after preparation. To a well in a 96-well 
microplate, 50 µL of sample was added to 200 µL of DCFH solution. Fluorescence 
measurement was started when 20 µL of 270 mM AAPH in PBS was added to the well. 
Peroxyl radicals generated from AAPH and unscavenged by antioxidants oxidize DCFH 
to result in fluorescent compound DCF. Varian Cary Eclipse fluorescence 
spectrophotometer was used for all fluorescence measurements. Assay was performed on 
a 96 well plate using a Varian microplate reader. Excitation and emission wavelengths 
were 502 nm and 525 nm respectively and slit width was 10 nm. Data was acquired using 
Cary Eclipse software from Varian. Assay was always calibrated using known trolox 
concentrations and the antioxidant potential of the sample was determined in terms of 
molar active trolox equivalents. 
4.2.8 Cytotoxicity of Poly(trolox ester) Nanoparticles 
Mouse pulmonary microvascular endothelial cells (MPMVEC) were isolated from 
mouse lungs as described previously [267]. MPMVEC were cultured in Dulbecco’s 
modified eagle medium (DMEM) supplemented with 10% fetal bovine serum, 1% 
nonessential amino acids and penicillin/streptomycin in a 96 well microplate overnight. 
Polymer nanoparticles at a concentration of 10 mg/ml in PBS were diluted in DMEM to 
different concentrations and added to the wells. 24 hrs after adding the nanoparticles, the 
cell viability was determined by CellTiter 96 AQueous Non-Radioactive Cell Proliferation 
Assay by  incubation with 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
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(4-sulfophenyl)-2H-tetrazolium (MTS) / phenazine methosulfate (PMS) mixture  at 37 0C 
for 3 hrs. MTS is reduced by dehydrogenase enzymes in metabolically active cells to a 
blue colored soluble formazan product. The absorbance of the formazan was then 
measured at 490  nm using a microplate reader (Synergy HT, BioTek, Vermont). 
4.3 Results and Discussion 
4.3.1 Synthesis and Characterization of Poly(trolox ester) 
 A carbodiimide based polymerization reaction was used for the synthesis of 
poly(trolox ester) (Figure 4-2). Initial trolox concentration was 16.7 mg/ml. The molar 
ratio of the reactants, DCC:trolox and DMAP:trolox, was 1.1 and 0.5, respectively. GPC 
results revealed the product to be oligomeric (i.e. ≤ 7 mers,   See Figure 4-3). Average 
molecular weight of the oligomers, referred to as PTx-1000, was MN = 830 and MW = 
1156 and possessed a polydispersity index of 1.4. Increasing the DCC:trolox and 
DMAP:trolox ratios to 1.5 and 1 respectively did not increase average molecular weight 
of oligomer (results not shown). As shown in Figure 4-2, esterification of trolox using a 
carbodiimide involves the formation of an active intermediate O-acyl urea. This 
intermediate can undergo molecular rearrangement (ON migration) to form N-acyl 
urea which results in terminal capping of reactive carboxylic group thereby preventing 
further polymer chain growth. [The peak at 171.75 in 13C NMR spectra of PTx-1000 
could be related to the N-acyl urea peak]. 
The rate of N-acyl urea formation depends on the pKa of the trolox carboxyl acid 
group (pKa = 3.89) [268] and solvent pH and can be suppressed by acid catalysis [265]. 
The reaction medium pH was lowered by using PTSA. A DMAP:PTSA ratio of 1:1 was 
maintained using separately synthesized DPTS. Initial trolox concentration was 37 mg/ml 
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in DCM and the ratio of DIC:trolox and DPTS:trolox was 1.5 and 1, respectively. Acid 
catalysis resulted in a polymer, referred as PTx-2500, with an average molecular weight 
of MN = 1294 and MW = 2520 which results in polydispersity index of 1.9. As shown in 
Figure 4-3, PTx-2500 possesses a significant fraction of higher molecular weight chains, 
up to 10,000 MW.  The peaks at wavelengths of 1747 cm-1 (ester carbonyl stretch) in the 
IR spectrum (Figure 4-4) and 172.5 ppm in the 13C NMR spectrum (Figure 4-5) are 
indicative of ester bonds in PTx-1000 and PTx-2500.  
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Figure 4-3. GPC analysis of PTx-1000 and PTx-2500  
Chromatograms of synthesized and purified PTx-1000 and PTx-2500 
obtained from GPC analysis. Presence of several peaks in PTx-1000 
chromatogram indicates that synthesis resulted in oligomers of trolox (MN 
= 830 and MW = 1156).  
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Figure 4-4. FTIR Spectra of Trolox, PTx-1000 and PTx-2500. 
 In the inset, peak at ~ 1747 cm-1 indicates presence of ester bond.  
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Figure 4-5. 13C NMR Analysis of Trolox, PTx-1000 and PTx-2500 
(Top) 13C NMR spectra of trolox, purified PTx-1000 and PTx-2500.  
(Bottom) Peak at 174.77 ppm in trolox spectrum is characteristic of 
carbonyl bond in a carboxylic acid. Peaks at 172.75 ppm is related to 
carbonyl bond in trolox ester. [Peak at 172 ppm in PTx-1000 spectra can 
be related to the N-acyl urea  present in PTx-1000]. 
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4.3.2 Poly(trolox ester) Nanoparticle Formulation and Characterization 
In order to study feasibility of antioxidant polymers for targeted vascular delivery 
of antioxidants, which is the long-term goal of the project, polymer nanoparticles were 
formulated using a single step emulsion technique. Pluronic F-68 was used as a surfactant 
to prevent nanoparticle aggregation. Size of poly(trolox ester) nanoparticles was 
controlled by varying the concentration of polymer in acetone during the single emulsion 
technique. To obtain PTx-1000 nanoparticles, a 1 wt% pluronic F-68 solution in 
phosphate buffered saline (PBS) was used. As PTx-1000 concentration in acetone was 
increased from 5 mg/ml to 25 mg/ml, size of the resultant nanoparticles changed from 
120 nm to 220 nm (Figure 4-6). However, when a 1 wt% pluronic F-68 solution was 
used for PTx-2500 nanoparticle formulation, it resulted in formation of many micron 
sized particles. This can be attributed to the increased viscosity of PTx-2500 solution in 
the organic solvent owing to its higher molecular weight. In order to minimize the 
formation of micron sized particles, surfactant concentration was increased from 1 wt% 
to 4 wt%. Before size measurement, PTx-2500 nanoparticle solutions were subjected to 
filtration using a 1 µm syringe filter to remove small fractions of micron sized particles. 
As PTx-2500 concentration in acetone was increased from 2.5 mg/ml to 7.5 mg/ml, size 
of the resultant nanoparticles changed from 170 nm to 230 nm (Figure 4-6). 
Immunotargeted intracellular delivery of nanocarriers to endothelium is size-dependant, 
and has been shown to be optimum for nanocarriers in range of 100-300 nm. Taking this 
into consideration, since a common size range of 180 – 220 nm for PTx-1000 and PTx-
2500 nanoparticles was achieved, PTx-2500 nanoparticles at concentrations lower than 
2.5 mg/ml were not formulated. 
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Figure 4-6. Tuning Particle Size by Changing the Concentration of Polymer in 
Organic Solvent. 
  
PTx-1000 (diamonds) and PTx-2500 (squares) nanoparticles were 
formulated using a single emulsion technique. Polymers were dissolved at 
different concentrations in acetone. Acetone solution was then added drop-
wise to pluronic F-68 solution in PBS. Surfactant solution concentration 
used for PTx-1000 and PTx-2500 nanoparticle formulation was 1 wt% and 
4 wt% respectively. In all the formulations, final acetone concentration in 
PBS was limited to 10%. Resulting particles were diluted 10 times and 
particle size was measured by dynamic light scattering (DLS) using a 
Malvern Zetasizer Nano. (M + SD, n=3). * represents that the data point is 
significantly different from previous data point in series with whereas # 
represents that the data point is not significantly different from previous 
data point in the series with p<0.05. 
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4.3.3 In Vitro Degradation of PTx-1000 and PTx-2500 Nanoparticles 
Antioxidant activity of poly(trolox ester) was verified by an in vitro degradation 
study. PTx-1000 (160 nm) and PTx-2500 (195 nm) nanoparticles at a concentration of 1 
mg/ml were incubated in PBS (pH 7.4) at 37 0C with and without the enzyme carbonic 
anhydrase (CA). In absence of CA, except for a small initial spike, no increase in the 
antioxidant activity of the nanoparticle suspension could be detected. However, results 
from in vitro oxidative stress studies suggested that PTx-1000 and PTx-2500 might be 
susceptible to enzymatic degradation. The enzyme, CA, was studied because it is known 
to have esterase activity to hydrolyze phenyl esters [269], and is localized in the cytosol 
as well as in/on the plasma membrane of a cell [270, 271].  As such, it is a likely 
candidate for in vitro degradation of nanoparticles. Indeed, in the presence of the enzyme 
CA, the antioxidant activity of the nanoparticle suspension increased from 0 µM to 70 µM 
over a period of 100 hrs (Figure 4-7).    
As we have observed that incubation of pure trolox in PBS loses its antioxidant 
activity with time, it is possible that some of the antioxidants released as the degradation 
products of poly(trolox ester) can undergo natural oxidation during the incubation period 
meaning that the measured antioxidant activity is an underestimation of actual 
antioxidant activity of nanoparticle suspension. Incubation of PTx-1000 and PTx-2500 
nanoparticles at 37 0C resulted in a significant increase in their size over the time. 
However, in the presence of CA, increase in the size was slightly higher as compared to 
the size increase during non-enzymatic incubation (Figure 4-7). As degradation of 
poly(trolox ester) nanoparticles proceeds, its hydrophilicity will increase resulting in the 
swelling of particles. Release of antioxidants and swelling of nanoparticles confirms that 
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PTx-1000 and PTx-2500 are more susceptible to enzymatic degradation as compared to 
hydrolytic degradation. 
4.3.4 Cytotoxicity of Poly(trolox ester) Nanoparticles  
Biocompatibility of the degradable polymer typically depends on the toxicity of 
its degradation and leachable products which are either oligomers or monomers. To study 
the biocompatibility of the poly(trolox ester) polymers, mouse pulmonary microvascular 
endothelial cells (MPMVEC) were exposed to PTx-1000 (195 nm) and PTx-2500 (215 
nm) nanoparticles at concentrations ranging from 3.9 µg/ml to 1000 µg/ml and cell 
viability was measured by CellTiter 96 AQueous using a Non-Radioactive Cell 
Proliferation Assay (MTS assay, Promega, Madison, WI) (Figure 4-8). Exposure of 
endothelial cells to PTx-1000 nanoparticles at concentrations up to 500 µg/ml did not 
result in any significant cytotoxic effects. When the concentration was increased to 1000 
µg/ml, the cell viability dropped marginally to 87.9 + 3.5 % as compared to the control. 
PTx-2500 nanoparticles did not have any significant cytotoxic effects in the 
concentration range studied. 
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Figure 4-7. Enzymatic Degradation of Poly(trolox ester) Nanoparticles  
Poly(trolox ester) nanoparticles were suspended in PBS at 37 0C at 
concentration of 1 mg/ml with(squares) and without(triangles) the enzyme 
CA. Aliquots were removed at different time points and were immediately 
used to measure antioxidant activity. Size of nanoparticles in all the 
suspensions was also measured at different time points. One-way ANOVA 
was performed on all the trends. All the trends were significant with 
p<0.05. 
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Figure 4-8. Cytotoxicity of Poly(trolox ester) Nanoparticles  
MPMVEC cultured in a 96 well plate were exposed to PTx-1000 (black) 
and PTx-2500 (grey) nanoparticles for 24 hrs. After 24 hrs, cell viability 
was measured using MTS assay. (M + SD, n=3). Cells without exposure 
were used as control. * represents significant difference from the control 
with p<0.05. 
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4.4 Conclusion 
In conclusion, trolox was polymerized successfully using carbodiimide based 
esterification reaction to result in two polymers of different molecular weights. 
Nanoparticles of PTx-1000 and PTx-2500 were formulated using single emulsion method 
with a control over their size. Formulation of poly(trolox ester) into nanoparticles will 
allow its characterization for drug delivery applications. In vitro degradation studies 
suggests that poly(trolox ester) is more susceptible to enzymatic degradation as compared 
to hydrolytic degradation. Also, degradation products of poly(trolox ester) have radical 
scavenging ability as determined by an in vitro assay. Poly(trolox ester) nanoparticles had 
very little to no cytotoxicity up to concentration of 1 mg/ml and will be characterized for 
their antioxidant activity in in vitro cell culture models.  
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Chapter 5. Effect of Poly(trolox ester) on Oxidative Stress in Cells 
Based on the research articles published in : 
P.P. Wattamwar, Y. Mo, R. Wan, R. Palli, Q. Zhang and T.D. Dziubla, 
“Antioxidant Activity of Degradable Polymer Poly(trolox) to Suppress 
Oxidative Stress Injury in the Cells”, Advanced Functional Materials, 
2010, 20, 147-154. 
P.P. Wattamwar
 
, S.S. Hardas, D. Allan Butterfield, K.W. Anderson and 
T.D. Dziubla, “Tuning of the Pro-oxidant and Antioxidant Activity of 
Trolox Through the Controlled Release from Biodegradable Poly(trolox 
ester) Polymers”, Journal of Biomedical Materials Research Part A, 2011, 
99A, 184-191. 
5.1 Introduction 
It is well known that, depending upon the setting, the degradation of 
biodegradable materials can result in a localized inflammatory response [272], which is 
often the result of accumulated degradable byproducts, inducing cellular oxidative stress 
[181, 182, 273, 274]. This observation has led to several groups developing antioxidant 
coupled biomaterials as a way of inhibiting localized biomaterial related inflammation 
[184, 186, 187, 256, 258, 275]. While this work has demonstrated an ability to suppress 
inflammation, little is known about the chemical targets in which these materials augment 
oxidative stress. For instance, the chronic inflammatory foreign body giant cell response 
is characterized by macrophages releasing a plethora of digestive enzymes and oxidative 
species like superoxide radical (O2.-). The enzyme superoxide dismutase (SOD) converts 
O2.- in to hydrogen peroxide (H2O2). H2O2 can then react with transient, redox active 
reduced metal ions (Fe2+, Cu+, etc.) to form hydroxyl radicals (OH.). O2.- can also react 
with nitric oxide (NO) to form peroxynitrite (ONOO-). These reactive oxygen species 
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(ROS) and reactive nitrogen species (RNS), respectively, can further react with and 
oxidatively damage cellular proteins and lipids thereby producing oxidative stress 
markers such as protein carbonyl, 3-nitrotyrosine (3NT) and 4-hydroxy-2-trans-nonenal 
(HNE) [276, 277]. The latter can covalently bind to Cys, His, and Lys residues on 
proteins via Michael addition, changing the structure and function of protein [278]. 
However, small molecule antioxidants can terminate different reactive species, e.g., water 
soluble antioxidants like gallic acid, vitamin C, trolox etc. eliminate radicals generated in 
the cytosolic cellular compartment, while hydrophobic antioxidants like vitamin E 
(tocopherol), β-carotene, etc. reduce lipid peroxidation. As such, antioxidants can 
modulate the redox state of the cell by controlling the levels of ROS and RNS [200]. 
Modulation of this redox state can induce various cell responses like cell proliferation, 
differentiation, inflammation, apoptosis, etc. [32-35]. Despite this control, of the tools 
available for designing biomaterials to modulate cellular/tissue behavior (e.g. growth 
factor release, cytokine/drug release, structural cues), redox status remains an 
underdeveloped yet exciting mechanism for controlling cellular response to biomaterials. 
As such, a knowledge of which chemical targets are affected can provide insight into 
which settings an oxidation sensitive biomaterial is most useful.  
As described in the previous chapter, we had synthesized poly(trolox ester), a 
biodegradable polymer of trolox that upon degradation results in release of active 
antioxidant trolox [256]. Trolox [ (+)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-
carboxylic acid ], a synthetic and water-soluble analogue of α-tocopherol (Vitamin E), 
has been shown to have antioxidant protective effect against oxidative stress injury [35, 
279-281]. In this work, we report that poly(trolox ester) provides protection against 
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cellular oxidative stress in an in vitro model where cobalt nanoparticles were used to 
induce cellular oxidative stress. However, the free antioxidant, trolox, is known to 
possess a concentration dependent antioxidant and pro-oxidant effect [282-284]. In the 
current study, it was found that the toxicity of trolox resulting from its pro-oxidant effect 
can be reduced by the slow release of trolox through biodegradation of poly(trolox ester). 
Further, it was found that the method of delivery altered what chemical target was 
protected from oxidation. Specifically, there was a dose-dependent suppression of protein 
oxidation (as monitored by protein carbonyl formation) for poly(trolox ester) 
nanoparticles and not free soluble trolox. This work details the importance of oxidized 
product analysis and highlights the advantages that the mechanism of delivery can have 
upon the therapeutic response. This result emphasizes the unique potential for antioxidant 
polymers like poly(trolox ester) in a variety of biomedical applications, including wound 
healing, improving implant response and tissue engineering applications. 
5.2 Antioxidant Mechanism of Trolox – Reactions of Trolox with Free Radicals 
While proposing to use trolox as a scavenger of biological oxidants, it is 
necessary to know their kinetics of scavenging which would determine their scavenging 
efficiency. Even though scavenging kinetics are much slower compared to enzymatic 
degradation of oxidants, they are fast enough to provide protection of biologically 
sensitive molecules. This section describes mechanism and kinetics of scavenging of 
biological oxidants by trolox. Except for phytyl chain in Vitamin E, trolox and Vit E are 
similar and hence their reactions with the free radicals are similar. 
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When small antioxidant molecules react with ROS, there is a transfer of the 
radical with the formation of less-reactive antioxidant-derived radical as shown below in 
reaction (1).  
AH + R
.
  A
.
 + RH (1) 
The antioxidant-derived radical is less reactive and has a life time longer than that of the 
oxidant initially scavenged. The reduction potentials of oxidants and antioxidants indicate 
stability of their radicals, where a higher reduction indicates a less stable radical and vice 
versa (Table 5-1) [285]. Trolox has a reduction potential lower than several biological 
free radicals and can be used as a potential antioxidant against these radicals. 
Reactions of trolox with ROS and RNS are summarized in Figure 5-1. Trolox is 
susceptible to OH. attack at various sites. Either, abstraction of phenolic hydrogen as 
shown in reaction (2) or addition to the phenolic ring to form an OH. adduct, as shown in 
reaction (3) and (5). OH. adduct then yields phenoxyl radical (TxO.) by elimination of 
water molecule (reaction (4) and (6)), which is a acid/base-catalyzed process. Reaction 
(7) represents overall formation of TxO. with a rate constant k7 determined as 6.9 x 109 
dm3/ mol/s [262]. 
 Pulse radiolysis studies of the reaction of trolox with O2.- indicate that trolox does 
not react with superoxide anion [261, 262]. However, electron spin resonance studies 
have shown that trolox can be oxidized by O2.- (reaction (8)), although in these studies, 
involvement of H2O2, protonated form of O2.-, is a possibility. The reaction rate of k8 = 
1.7 x 104 dm3/ mol/s has been reported [262]. Also, it has been reported that superoxide 
anion can react with the trolox phenoxyl radical by the reaction (9). The  
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Table 5-1 One-electron Reduction Potentials of Some Oxidants and 
Antioxidants. 
 
  All listed potentials were obtained at pH 7[285]. 
Species Redox Couple E0 (mV) 
Hydroxyl radical, OH. H+ / H2O 2310 
Aliphatic alkoxyl radical, LO.  H+ / LOH 1600 
Peroxynitrite, ONOO- ONOOH / NO. 1400 
Alkyl peroxyl radical, LOO. H+ / LOOH 1000 
Polyunsaturated fatty acid radical, L.  H+ / LH 600 
α-tocopheroxyl radical, T-O. H+ / T-OH 500 
Trolox radical, T-O. H+ / T-OH 480 
H2O2 H+ / H2O,OH. 320 
Ascorbate radical, Asc. H+ / Ascorbate monoanion 282 
O2.- O2 / O2.- -330 
 
 
 
 
 
 
 
 
 
 
 
 80 
 
 
Figure 5-1. Reactions of Trolox with ROS and RNS. 
(Reactions 2-7) Reactions of trolox with hydroxyl radical. (2) 
Hydrogen abstraction from phenolic group to form phenoxyl radical. (3) & 
(5) Addition of OH. to phenolic ring to form a OH. adduct. (4) & (6) OH. 
adduct further forms phenoxyl radical by elimination of water molecule. 
(7) Represents the overall formation of phenoxyl radical under a range of 
pH.  Reactions (3) and (4) represent reactions at neutral pH, whereas 
reactions (5) and (6) represent reactions at basic pH. TxOH : Trolox, TxO. 
: Trolox phenoxyl radical, TxOH(OH). : OH. adduct with Tx 
 
(Reactions 8 and 9) Reactions of trolox with O2.- 
 
(Reactions 10-12) Reactions of trolox with RNS. TxOH/TxO-: Trolox in 
protonated and deprotonated form, ONOOH/ONOO-: peroxynitrite in 
protonated and deprotonated form, NO2: Nitrite radical, TxO.: Trolox 
phenoxyl radical  
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reaction rate k9 for reaction (9) has been reported as (4.5 + 0.5) x 108 M-1.s-1 [261]. 
Reaction (9) can be seen as a reaction for scavenging O2.- as well as for regeneration of 
TxOH. 
 Reactions of trolox with reactive nitrogen species (RNS) like ONOO- and NO2 are 
shown at the bottom of Figure 5-1. Trolox can undergo both one electron and two 
electron oxidation reactions depending on the concentration of peroxynitrite present. All 
the reaction rates depend on pH of solution due to prototropic equilibria of both trolox 
and peroxynitrite. In the range of pH 5.9 – 11, k10 and k12 have been reported as 8.3 – 3.4 
x 104 and 6.4 – 1.6 x 103 M-1.s-1 respectively. At neutral pH, rate constant k11 has been 
reported to be < 105 M-1.s-1 [263].  
Pro-oxidant effects of Vitamin E, Vitamin C and trolox have been reported 
previously [283, 286, 287], where antioxidant radicals react with low density lipoproteins 
(LDL), resulting in further generation of lipid radicals. It was observed that trolox 
behaves like a prooxidant only when radicals were generated using metal ions like Cu2+ 
or Cr(VI). Many of these transient metal ions are present in vivo. Trolox always acts like 
an antioxidant when peroxyl radicals were generated. It can be argued that, in presence of 
metal ions, trolox acts to reduce metal ions leading to excess generation of trolox 
phenoxyl radical. In absence of metal ions and oxygen, trolox phenoxyl radical undergoes 
a disproportionation reaction and a associated intramolecular cyclization (Figure 5-2) at 
a significant rate [288]. Vitamin E acted as a prooxidant only under high concentrations 
and exerted a better antioxidant effect at low concentrations [289]. In absence of oxygen, 
Vitamin E phenoxyl radical undergoes dimerization reaction [290]. Therefore,  
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Figure 5-2. Decay Reactions of Trolox Phenoxyl Radical [288].  
TxO- disproportionates by a second-order, pH dependent process to give 
trolox and a unstable ketodiene intermediate. In a second reaction, 
ketodiene intermediate undergoes a slow pH dependent hydrolysis to form 
trolox quinone. The disproportionation reaction rate constant ranges from 
109 – 104 M-1.s-1 and decreases with increase in pH and maximum decrease 
occurs between pH 2- 9. The reaction rate constant of intermediate 
decomposition ranges between 0.9 – 0.02 M-1.s-1 in a pH range of 2 – 10 
and it increases with pH [288]. 
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antioxidant or prooxidant capacity of both trolox and Vitamin E depends on their 
concentrations and physiological conditions. 
5.3 Materials and Methods 
5.3.1 Materials 
All reagents were used as received without any further purification. (+)-6-
Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox), 3-(4,5-Dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and Pluronic F-68 were 
purchased from Sigma-Aldrich (St. Louis, MO). 2’,7’-dichlorodihydrofluorescein 
diacetate (DCF-DA) and Live/Dead® cell viability assay were purchased from Invitrogen 
(Carlsbad, CA). All solvents were either obtained from Sigma-Aldrich or Fisher 
Scientific. Anti-nitrotyrosine antibody, Anti-dinitrophenylhydrazine (DNPH) protein 
antibody and HNE anti-body were purchased from Intergen (Purchase, NY) and 
Millipore (Billerica, MA). 
5.3.2 Poly(trolox ester) Nanoparticle Formulation 
PTx-1000 and PTx-2500 nanoparticles were formulated as previously described 
[256]. Briefly, polymer solution in acetone (10 mg/mL PTx-1000 and 2 mg/mL PTx-
2500) was added to a pluronic F-68 solution in PBS while stirring. The resulting 
nanoparticle solution was left open overnight under stirring conditions to allow 
evaporation of the acetone. To remove excess surfactant, the nanoparticle suspension was 
centrifuged at 22000 rpm for 2 hrs. Supernatant was discarded and the pellet was 
resuspended in 40 mL phosphate buffered saline (PBS). Centrifugation was repeated two 
more times and cell media was used for final resuspension of the pellet. Nanoparticle size 
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was measured using dynamic light scattering on a Malvern Zetasizer Nano 
(Westborough, MA). Nanoparticles free of excess surfactant and of size 180-200 nm 
were used for all the studies. 
5.3.3 In Vitro Cell Protection Against Oxidative Stress 
Human leukemic monocyte lymphoma cells (U937) were obtained from 
American Type Culture Collection (ATCC) (Rockville, MD) and cultured in RPMI 1640 
medium (Mediatech Inc., Manassas, VA) supplemented with 10% fetal bovine serum and 
penicillin/streptomycin. 96 well microplate was seeded with U937 cells at a seeding 
density of 70000 cells/well and cultured overnight.  DCF-DA at a concentration of 5 µM 
was added and one hour later, polymer nanoparticles were added. Another hour later, 
oxidative stress was induced in the cells by adding cobalt nanoparticles (Nano-Co). 12 
hrs later, fluorescence was measured from top at an excitation wavelength of 485 nm and 
emission wavelength of 528 nm using multi-detection microplate reader. Percent 
protection from injury by the antioxidant polymer was calculated by the following 
equation. 
controlinjured
sampleinjured
ceFluorescenceFluorescen
ceFluorescenceFluorescen
protection
−
−
=%  
5.3.4 Cell Line 
Human umbilical vein endothelial cells (HUVECs) were purchased from Lonza. 
Cells were cultured in EGM-2 medium with 2% fetal bovine serum at 37 0C in a 
humidified atmosphere of 5% CO2 (v/v). All the studies with HUVECs have been 
conducted with cells from passage 3 to 5 and at 90% confluency.  
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5.3.5 Measuring Oxidative Stress in Cells Using DCF Fluorescence 
HUVECs were seeded onto a 96-well plate at a density of 25000 cells/cm2 and 
incubated at 37 0C in a humidified atmosphere of 95% air and 5% CO2. After 24 h, 
medium in each well was replaced by 100 µL of treatment solution [trolox solution or 
poly(trolox ester) nanoparticle suspension in media] and 100 µL of 10 µM DCF-DA 
solution in media. Fluorescence was then measured at various time points using a bottom-
reading GENios Pro fluorescence spectrophotometer (Tecan, Switzerland) at excitation 
and emission wavelengths of 485 nm and 535 nm, respectively. Well plates were 
incubated at 37 0C throughout the study and briefly taken out of the incubator for 
fluorescence measurements at each time point. 
5.3.6 Cytotoxicity of Trolox, Poly(trolox ester) Nanoparticles and Nanoparticle 
Leachouts 
Cytotoxicity of trolox was determined using a standard MTT assay according to 
manufacturer’s protocol. Active reductase enzymes in the cell convert MTT into a 
colored formazan product which is then measured using UV spectrophotometry. 
HUVECs were seeded onto a 96-well plate at a density of 25000 cells/cm2. After 24 h, 
media in the wells was removed and replaced by trolox solution in cell media. Freshly 
prepared 250 mM trolox stock solution in DMSO was diluted in cell media to prepare 
trolox solutions. Another 24 h later, trolox solution was removed and cells were washed 
twice with 200 µL PBS. 200 µL of 0.5 mg/mL MTT solution in PBS was then added to 
each well and the 96-well plate was incubated at 37 0C. After 5 h, MTT solution was 
gently removed from the wells and 100 µL of DMSO was added to dissolve the formazan 
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product. The absorbance intensity was recorded at 570 nm for formazan and at 690 nm 
for background using a Cary-50 Bio UV-Visible spectrophotometer equipped with a Cary 
50 MPR microplate reader (Varian, Santa Clara, CA). 
Toxicity of poly(trolox ester) nanoparticles to  mouse pulmonary microvascular 
endothelial cells (MPMVEC) as measured by MTS assay (modification of MTT assay) 
has been reported previously [256]. Hence, in this study, cytotoxicity of PTx-1000 and 
PTx-2500 nanoparticles was determined using Live/Dead Viability Assay (Molecular 
Probes) according to manufacturer’s protocol. HUVECs were seeded onto a 24-well plate 
at a cell density of 25000 cells/cm2. After 24 h, cell media was replaced with 0.5 mL of 
nanoparticle suspensions in cell media. After another 24 h, nanoparticle solution was 
removed from each well and cells were washed twice with 2 mL of PBS. Cells were then 
stained with two-color fluorescence Live/Dead assay. They were then imaged via 
fluorescence microscopy where the live cells fluoresced green and the dead cells 
fluoresced red. The live and dead cells were counted using NIS-Elements software 
(Nikon Instruments, Melville, NY). The cell viability was then calculated as the number 
of live cells over the total number of live and dead cells. 
To study the cytotoxicity of nanoparticle leachouts, HUVECs were seeded onto a 
24-well plate at a cell density of 25000 cells/cm2. After 24 h, media was taken out of each 
well. Cell media (250 µL) was added to the well and a porous insert (NuncTM cell culture 
insert with 0.02 µm pore size AnaporeTM membrane) was placed in each well. Another 
250 µL of media or nanoparticle suspension was added to the insert. Cell viability was 
measured after 24 h using Live/Dead assay as described above. 
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5.3.7 Measurement of Protein Carbonyls, 3-nitrotyrosine (3NT) and Protein 
Bound 4-hydroxy-2-trans-nonenal (HNE) as Markers of Oxidative Stress  
HUVECs were seeded on to a 6-well plate at a cell density of 25000 cells/cm2. 24 
h later, cell media from the well was replaced by 2 mL of treatment solution in media. 
Twenty-four h after the treatment, solution above the cells was removed and cells were 
washed twice with chilled PBS. Cells were then scraped and centrifuged. Cell pellet was 
then lysed using a cell lysis buffer, the latter prepared by mixing RIPA buffer (pH = 8.0) 
and protease inhibitor cocktail (Amresco, Solon, OH) using manufacturer’s protocol. 
Levels of protein carbonyl, 3NT and HNE were measured by slot blot technique 
[291, 292]. Briefly, for protein carbonyl levels, each sample was derivatized by 
incubating with 5µL of 12% SDS and 10mM solution of 2,4-dinitrophenylhydrazine 
(DNPH) in 2N HCl for 20 min at room temp followed by a 7.5 µL addition of a 
neutralization solution (2M Tris in 30% glycerol).  The sample was then used for slot blot 
analysis. Whereas, for 3NT and protein bound HNE levels, samples were denatured in 
5µL of 12% SDS solution and Laemmli sample buffer. Specific antibodies were used 
against protein carbonyl, 3NT or HNE protein modifications and colorimetric technique 
was used for detection as described previously [291, 292]. 
Statistical analysis 
Treatment comparisons were made using analysis of variance (ANOVA) followed 
by post hoc Student’s t-test. Contrasts were considered significantly different at P < 0.05. 
Data are reported as mean + standard errors. 
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5.4 Results 
5.4.1 Nano-Co Induced Oxidative Stress Injury and Protection from Poly(trolox 
ester) Nanoparticles 
To measure the effect of Nano-CO treatment on oxidative stress levels in U937 
cells, DCF fluorescence was measured as percent of control (0 µg/ml Nano-Co) (Figure 
5-3). DCF fluorescence increased with increase in Nano-Co concentration and for Nano-
Co concentrations of 2.5 and 5 µg/ml, DCF fluorescence was maximum at 12 h, after 
which DCF fluorescence started decreasing.  
To study the protective effect of poly(trolox ester) nanoparticles, human U937 
monocytes were exposed to PTx-1000 (180 nm) and PTx-2500 nanoparticles (215 nm) 1 
hr prior to inducing oxidative stress by exposure to Nano-Co particles. PTx-1000 and 
PTx-2500 nanoparticles at concentrations of 160 and 320 µg/ml, where they have no 
severe cytotoxic effect, were studied. Oxidative stress was measured by measuring DCF 
fluorescence after treatment with Nano-Co  (Figure 5-4). Without the addition of Nano-
Co to the cells, incubation of PTx-1000 and PTx-2500 nanoparticles with the cells for 12 
hrs reduced the background oxidative stress in the cells by 40% and 25% respectively. 
Pre-incubation of cells with poly(trolox ester) nanoparticles prior to adding Nano-Co, 
suppressed the oxidative stress in the cells by 40-50% in case of PTx-1000 nanoparticles 
and 25-40% in case of PTx-2500 nanoparticles. 
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Figure 5-3. Oxidative Stress Injury Model.  
U937 cells were treated with Nano-Co at concentrations of 2.5 and 5 µg 
ml-1. DCF fluorescence, a marker of oxidative stress in the cells, was 
measured at different times. For both the concentrations of Nano-Co, cells 
experience maximum oxidative stress after 12 hrs of Nano-Co addition. 
(M + SD, n=3). * represents significant difference from 6h and 24h data 
points with p<0.05. 
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Figure 5-4. Cell Protection Against Oxidative Stress by Poly(trolox ester) 
Nanoparticles. 
  
One hour after adding DCF to the U937 cells, PTx-1000 nanoparticles (top left) 
and PTx-2500 nanoparticles (top right) were added to the cells at concentrations 
of 160 and 320 µg ml-1 and PLA nanoparticles (bottom left) were added to the 
cells at concentrations of 500 and 1000 µg ml-1. Another hour later Nano-Co was 
added at concentrations of 2.5 and 5 µg ml-1. 12 hrs after the addition of Nano-
Co, DCF fluorescence was measured. % Protection of cells from the oxidative 
stress injury using PTx-1000 and PTx-2500 nanoparticles at different 
concentrations  (bottom right).  (M + SD, n=3). * represents significant 
difference from respective control values with p<0.05. 
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5.4.2 Effect of Trolox and Poly(trolox ester) Nanoparticles on Background 
Oxidative Stress in the Cells 
Effect of trolox on the oxidative stress levels in the cells was measured using DCF 
fluorescence (used as a marker of oxidative stress) in HUVECs (Fig. 1). Fluorescence 
intensities as percent of control at 27 h time are compared in Figure 5-5. Trolox at lower 
concentrations suppresses oxidative stress in the cells as indicated by reduced 
fluorescence as compared to the control. At concentrations of trolox from 50 to 125 
µg/mL, the DCF fluorescence in the cells is lower than control, but higher as compared to 
fluorescence at 25 µg/mL. DCF fluorescence increases with increasing trolox 
concentration in the range of 50 to 1000 µg/mL, where the fluorescence at 1000 µg/mL is 
almost eight times that of the control (0 ug/ml trolox). 
In a similar study, PTx-1000 and PTx-2500 nanoparticles followed by DCF-DA 
solution were added to HUVECs and fluorescence was measured after 27 h (Figure 5-6). 
In the case of PTx-1000 nanoparticles, DCF fluorescence at 27 h decreases with 
increasing nanoparticle concentration up to 1000 µg/mL. At concentrations of 2000 and 
4000 µg/mL of PTx-1000 nanoparticles, an increase in the fluorescence is observed 
compared to the fluorescence at 1000 µg/ml. DCF fluorescence is increasingly 
suppressed with an increase in PTx-2500 nanoparticle concentration. 
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Figure 5-5. Effect of Trolox on Oxidative Stress Level in HUVECs. 
Trolox solution in HUVEC media was added at different concentrations to 
HUVECs cultured in a 96-well plate. Fluorescence was measured after 27 
h using a bottom reading fluorescence spectrophotometer set at 485/535 
nm excitation and emission. (n=5, M+SE) 
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Figure 5-6. Effect of Poly(trolox ester) Nanoparticles on Oxidative Stress in 
HUVECs.  
 
PTx-1000 (grey) and PTx-2500 (black) nanoparticles suspended in EGM-
2 media at different concentrations were added to HUVECs cultured in 
96-well plate and fluorescence measured after 27 h is compared with 
control. ANOVA analysis of data indicates that the trends are significant 
for both PTx-1000 and PTx-2500 nanoparticles. (n=5, M+SE) 
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5.4.3 Cytotoxicity of Trolox, Poly(trolox ester) Nanoparticles and Their Leachouts  
HUVECs were treated with trolox solutions of different concentrations for 24 h 
and the cell viability was measured using MTT assay (Figure 5-7). Trolox at 
concentrations up to 500 µg/mL does not have any significant toxicity as compared to the 
control. However, cell viability at 1000 µg/mL significantly decreased to just above 70%. 
To study the cytotoxicity of poly(trolox ester) nanoparticles,  PTx-1000 and PTx-
2500 nanoparticles were added to HUVECs at different concentrations and cell viability 
was measured after 24 h using Live/Dead assay (Figure 5-8). In the concentration range 
studied here, cell viability did not change significantly as compared to control.    
In order to study the cytotoxicity of poly(trolox ester) nanoparticle leachouts, 
poly(trolox ester) nanoparticles suspended at concentration of 1 mg/mL were physically 
separated from HUVECs using a porous membrane support with pore size of 20 nm. 
Viability of the HUVECs exposed to poly(trolox ester) leachouts did not change 
significantly as compared to control (Figure 5-9). 
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Figure 5-7. Cytotoxicity of Trolox.  
HUVECs were treated with trolox at different concentrations for 24 h. Cell 
viability was measured using MTT assay. Trolox has significant (*) 
cytotoxicity only at 1000 µg/mL concentration (p < 0.05). (n=5, M+SE) 
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Figure 5-8. Cytotoxicity of Poly(trolox ester) Nanoparticles.  
HUVECs were treated with PTx-1000 nanoparticles (grey) and PTx-2500 
nanoparticles (black) for 24 h. Cell viability was measured using the 
Live/Dead assay. One-way ANOVA was performed and the trends were 
insignificant with p < 0.05. PTx-1000 and PTx-2500 nanoparticles do not 
have any significant toxicity to HUVECs. (n=3, M+SE) 
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(A) 
 
(B) 
Figure 5-9. Cytotoxicity of Poly(trolox ester) Leachouts. 
(A) Schematic showing nanoparticles separated from cells by porous 
membrane 
(B) HUVECs were treated with PTx-1000 and PTx-2500 nanoparticle 
leachouts for 24 h. Poly(trolox ester) nanoparticles at concentration of 
1 mg/mL were suspended in EGM-2 media on a porous insert above 
confluent HUVECs cultured in 24-well plates. Cell viability was 
measured using the Live/Dead assay. (n=3, M+SE) 
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5.4.4 Oxidized Cellular Proteins (protein carbonyl, 3-NT and HNE levels) as 
Markers of Oxidative Stress  
HUVECs were exposed to free trolox, PTx-1000 and PTx-2500 nanoparticles for 
24 h. After three washes with phosphate buffered saline solution, cells were lysed and 
cellular protein was collected as described in methods section. Protein samples were then 
analyzed for protein carbonyl (Figure 5-10A), 3-NT (Figure 5-10B) and protein-bound 
HNE (Figure 5-10C) levels. Treatment of HUVECs with trolox did not show any 
significant difference from control in any of the three markers.  Protein carbonyl content 
decreased as compared to control for cells treated with PTx-1000 and PTx-2500 
nanoparticles at concentrations of 1 mg/ml. At lower concentrations (0.1 mg/ml) of PTx-
1000 and PTx-2500 nanoparticles, there was no significant change in protein carbonyl 
content. Nanoparticle treatments did not show any significant difference from control for 
3-NT and protein-bound HNE levels, though a non-significant trend in 3-NT levels 
suggests that there were two measures of oxidative stress which were observed to be 
lower for the PTx-1000 nanoparticles. 
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Figure 5-10. Monitoring Oxidative Stress Levels in HUVECs.  
Cells were treated with free trolox, PTx-1000 and PTx-2500 at two 
different concentrations for 24 h. Cells were then lysed and collected 
protein was analyzed for a.) protein carbonyl content, b.) 3-NT levels and 
c.) protein-bound HNE levels using immunochemical methods. One-way 
ANOVA was performed on all the data sets. The trend is significant only 
for the protein carbonyl levels, but not for 3-NT and HNE levels. (n=3, 
M+SE) 
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5.5 Discussion 
 In vitro degradation studies of poly(trolox ester) nanoparticles had found that 
degradation products of PTx-1000 and PTx-2500 nanoparticles had radical scavenging 
activity. In order to confirm this result, PTx-1000 and PTx-2500 nanoparticles were 
tested in an in vitro oxidative stress-based cell injury model. It is known that exposure of 
cells to metal and metal oxide nanoparticles could induce a range of biological responses 
including cytotoxicity and inflammation, often mediated by oxidative stress mechanisms 
[293-295]. In this study, oxidative stress injury was induced in the monocytes with 
exposure to cobalt nanoparticles (Nano-Co). It has been shown previously that addition 
of Nano-Co leads to ROS generation in U937 cells [294]. A time-dependent and dose-
dependent effect of only Nano-Co was studied to find the time and concentration at 
which maximum ROS generation was observed. DCF fluorescence which is indicative of 
oxidative stress injury in the cells, is maximum at 12 hrs after exposure to Nano-Co and 
increases with increase in Nano-Co concentration (Figure 5-3). Therefore to study the 
extent of protection provided by poly(trolox ester) nanoparticles, oxidative stress in cells 
was monitored 12 hrs after induction of injury. 
 Poly(trolox ester) nanoparticles suppressed the Nano-Co induced oxidative stress 
in the cells by 40-50% in case of PTx-1000 nanoparticles and 25-40% in case of PTx-
2500 nanoparticles (Figure 5-4). It is hypothesized that lower degree of protection by 
PTx-2500 nanoparticles can be a result of slower release of trolox from PTx-2500 
nanoparticles. Also, protection provided by poly(trolox ester) nanoparticles was 
independent of the dose of nanoparticles. This could be explained by the inability of 
trolox monomer to completely suppress the oxidative damage caused by Nano-Co injury. 
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Dose-dependent effect of trolox monomer in the presence of Nano-Co injury shows that 
trolox at a concentration of 50 µg/ml  suppressed DCF fluorescence by 45% (Figure 5-
11). In a control set of experiments, poly(lactic acid) (PLA) nanoparticles with an 
average size of 280 nm were added to the cells prior to adding Nano-Co particles and 
PLA nanoparticles were unable to suppress oxidative stress in the cells (Figure 5-4). 
PLA nanoparticles were formulated using similar single-step emulsion technique as used 
for poly(trolox ester) nanoparticle formulation. 
It was observed that, without the addition of Nano-Co to the cells, incubation of 
trolox, PTx-1000 and PTx-2500 nanoparticles with the cells for 12 hrs reduced the 
background oxidative stress in the cells by 50%, 40% and 25% respectively (Figure 5-4 
and Figure 5-11). While further studying this effect of trolox and poly(trolox ester) 
nanoparticles on background oxidative stress in the HUVECs, it was found that trolox has 
a concentration dependant antioxidant and pro-oxidant effect (Figure 5-5).      
This concentration dependent biphasic behavior of antioxidants in both in vitro 
and in vivo settings has been illustrated in the literature [249, 250, 280, 282-284, 296-
298]. In a healthy cell/tissue, there is a balance between the rate at which ROS and RNS 
are generated and the rates at which antioxidant defense mechanisms terminate the 
reactive species. Any change in the antioxidant reservoir concentration or rate of 
generation of free radicals can change the redox state of the cell/tissue. A change in redox 
state can induce different cellular responses ranging from cellular apoptosis to cell 
differentiation [34, 299, 300]. This two-way antioxidant and pro-oxidant effect can be 
used in tissue engineering applications to control the oxidative stress level in the cells and  
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Figure 5-11. Cell Protection Against Oxidative Stress by Trolox Monomer.   
One hour after adding DCF to the U937 cells, trolox was added to the cells 
at concentrations of 6 – 50 µg/ml. Another hour later Nano-Co was added 
at concentrations of 2.5 and 5 µg ml-1. 12 hrs after the addition of Nano-
Co, DCF fluorescence was measured. (M + SD, n=3). 
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thereby modulate cell response. Polymers composed of antioxidants linked through 
hydrolysable bonds provide a means of controlling release of these antioxidants and 
thereby affect the redox state of the cell. 
Phenolic antioxidants (A-OH) like trolox can react with and terminate free radical 
species (R.) resulting in a stable phenoxyl radical (A-O.). In a normal cell/tissue, various 
small molecule antioxidants exert antioxidant effects synergistically where other 
antioxidants with reduction potential lower than A-O. can regenerate A-OH. The 
mechanisms by which antioxidants can act as pro-oxidants vary depending on that 
particular antioxidant and its environment. Some of the mechanisms that could result in 
pro-oxidant effects are depletion of glutathione [249, 297], the presence of reduced 
transition metal (Fe, Cu) ions [250, 296, 301], blocking several biomolecular targets like 
kinases and other proteins,  etc. Even though the biphasic effect of trolox represented by 
the U-shaped bar graph in Figure 5-5 has been reported in the literature [284, 302-304], 
the exact mechanism for its pro-oxidant activity is not known. Trolox (T-OH) can react 
with a free radical (R.) to from trolox phenoxyl radical (T-O.) and R-H. The resulting T-
O.  is more stable as compared to R. and can trap another free radical to give a trolox 
quinone  [261, 263, 305]. If trolox is present in excess as compared to the rate of 
generation of free radicals, the system will have equivalent amount of trolox converted 
into trolox phenoxyl radical which can in turn oxidize species that have lower redox 
potential.  
DCF fluorescence is a widely used model to study oxidative stress injury. DCF-
DA (2’,7’-dichlorodihydrofluorescin diacetate), a non-fluorescent ester form of the dye, 
is taken up by the cells and cleaved to non-fluorescent DCFH (2’,7’-
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dichlorodihydrofluorescin) by active esterases in the cell. DCFH can then react with free 
radicals to result in fluorescent DCF (2’,7’-dichlorofluorescin) a marker of oxidative 
stress in the cells. DCF fluorescence data in Figure 5-5 suggest that the critical trolox 
concentration for HUVECs at which trolox starts showing pro-oxidant effects is 
approximately between 25 to 50 µg/mL. 
Even though the DCF fluorescence model is simple and widely used, it is an 
indirect and general marker of overall oxidative stress in the cell and does not provide 
information regarding which specific oxidative species are responsible for oxidation of 
DCFH [306-309], nor what cellular components are at risk of damage. Indeed, DCFH can 
not only be oxidized by variety of oxidative species like ONOO-, OH., lipid peroxides, 
thiol radicals, etc., but could also be oxidized by antioxidant radicals (T-O.). DCF 
fluorescence data should therefore be interpreted with caution. As compared to the DCF 
fluorescence, markers of oxidative stress like protein carbonyl, 3NT and protein-bound 
HNE are direct evidence of damage occurred to proteins, enzymes and lipids at cellular 
levels and are quantitative. Also, 3-NT and protein-bound HNE are markers specific for 
protein damage by RNS and lipid peroxidation, respectively. Generalized protein 
oxidation can be detected through monitoring the extent of protein carbonyl content 
contained within the cell, with an increase indicating an elevation in protein oxidation. 
Proteins obtained after treatment of HUVECs with free trolox, PTx-1000 and PTx-2500 
nanoparticles were analyzed for their protein carbonyl, 3-NT and protein-bound HNE 
content. Both PTx-1000 and PTx-2500 nanoparticles at 1 mg/mL showed a significant 
difference in protein carbonyl content, suggesting a unique anti-oxidant protective effect. 
Neither antioxidant nor pro-oxidant effect of free trolox was observed using any of the 
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three markers, suggesting that the DCF fluorescence increase observed may be a “false 
positive”, further emphasizing the importance of secondary validation when monitoring 
cellular oxidative stress.  
The advantage of having antioxidant polymers like poly(trolox ester) is that they 
can be used to deliver antioxidants in gradual and controlled manner as compared to 
initial pulse dose of antioxidants. Our previous work on poly(trolox ester) suggests the 
polymer undergoes enzymatic degradation to release active antioxidants [256]. As shown 
in Figure 5-6, treatment of HUVECs with PTx-1000 and PTx-2500 nanoparticles 
resulted in suppression of DCF fluorescence in a concentration dependent manner. To 
rule out the possibility of this suppression of fluorescence as result of cell death, 
cytotoxicity of trolox monomer, PTx-1000 and PTx-2500 nanoparticles was determined. 
As shown in Figure 5-7, trolox has significant cytotoxicity at concentration of 1000 
µg/ml. While toxicity of trolox at higher concentrations was thought to be a result of its 
pro-oxidant effect as observed by DCF fluorescence studies, the lack of oxidative 
products (Figure 5-10) suggest an alternate mechanism for this cell death.  
PTx-1000 and PTx-2500 have very little to no cytotoxicity to HUVECs as 
indicated by the cell viability data in Figure 5-8. This study conforms with our previous 
findings regarding poly(trolox ester) nanoparticles having very little to no cytotoxicity to 
mouse pulmonary microvascular endothelial cells (MPMVEC), where cell viability was 
measured using the MTS assay [256]. However, cytotoxicity could also result from 
degradation products or the leachouts from poly(trolox ester) nanoparticles. To determine 
cytotoxicity of leachouts, poly(trolox ester) nanoparticles were suspended in a porous 
support above a confluent layer of HUVECs. The porous support (Nunc cell culture 
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inserts, 0.02 µm Anapore membrane) had a pore size of ~ 20 nm which would prevent 
nanoparticles of 180-200 nm from interacting with cells. However, water soluble 
leachouts from nanoparticles can diffuse through the membrane and interact with the 
cells. Poly(trolox ester) nanoparticle leachouts do not have any significant cytotoxicity as 
shown in Figure 5-9. Insignificant cytotoxicity of poly(trolox ester) nanoparticles and 
leachouts suggests that the suppression of DCF fluorescence by PTx-1000 and PTx-2500 
treatment is a result of the antioxidant effect. The antioxidant effect of poly(trolox ester) 
was also verified by the protein carbonyl data, where PTx-1000 and PTx-2500 
nanoparticles at higher concentrations suppressed protein carbonyl content in HUVECs. 
PTx-1000 nanoparticles suppress DCF fluorescence more as compared to PTx-2500 
nanoparticles. This conceivably can result from a difference in the degradation rate of the 
polymers and hence trolox being released at difference rates. PTx-1000 is more 
hydrophilic as compared to PTx-2500 and would degrade faster due to its lower 
molecular weight. A similar trend was observed where PTx-1000 nanoparticles provided 
more protection from oxidative stress injury in a in vitro model as compared to PTx-2500 
nanoparticles (Figure 5-4). Increased DCF fluorescence at higher PTx-1000 nanoparticle 
concentrations of 2000 and 4000 µg/mL indicates the pro-oxidant effect of PTx-1000. 
Biphasic DCF monitored antioxidant and pro-oxidant behavior of trolox could be 
recreated using PTx-1000 nanoparticles, where PTx-1000 acts as a pro-oxidant at very 
high concentrations. 
5.6 Conclusions 
Poly(trolox ester) has very little to no cytotoxicity and suppresses almost 50% of 
oxidative stress in the cells induced by nanometals. Also, poly(trolox ester) nanoparticles 
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affect the redox state of the cells as confirmed by DCF fluorescence  and protein carbonyl 
measurements in HUVECs. The polymer form of trolox possessed a unique ability to 
suppress protein oxidation not seen with the free trolox samples, emphasizing the 
importance of delivery route in modulating the potential therapeutic effect of antioxidant 
drugs. While DCF demonstrated a biphasic antioxidant/pro-oxidant effect of trolox, 
monitored cellular oxidative stress products did not exhibit this effect.  Because of the 
slow release of trolox through its biodegradation, poly(trolox ester) is an effective means 
of modulating cellular redox states. This capability has far reaching implications in the 
use of antioxidant polymers as a means of controlling cell status for a variety of 
biomedical, pharmaceutical and tissue engineering applications. 
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Chapter 6. A Single-step Polymerization Method for Poly(β-amino ester) 
Biodegradable Hydrogels and Their Characterization 
Chapter partly based on the research articles published in : 
D. Biswal, P.P. Wattamwar
My contribution in this research article was to synthesize hydrogels,characterize 
swelling response of synthesized hydrogels in organic solvents and to determine 
mechanical properties of the gels. 
, T.D. Dziubla and J.Z. Hilt, “Poly(β-amino 
ester) Hydrogel Synthesis by Single Step Polymerization Method”, 
Polymer, 2011, 52, 5985-5992. 
P.P. Wattamwar
 
, D. Biswal, A. Lyvers, D. Cochran, J.Z. Hilt and T.D. Dziubla, 
“Synthesis and Characterization of Poly(antioxidant β-amino esters) for 
Controlled Release of Polyphenolic Antioxidants”, Acta Biomaterialia (to be 
Submitted) 
6.1 Introduction 
 As described in the previous chapters, poly(trolox ester) is capable of degrading 
and releasing trolox, resulting in the suppression of cellular oxidative stress. While this 
work is promising and serves as a antioxidant polymer proof-of-concept, poly(trolox 
ester) has its own set of limitations, which reduces enthusiasm for their use. Degradation 
of poly(trolox ester) by hydrolysis is very slow and it requires enzymatic degradation to 
see functional effects, allowing little to no control over the rate of polymer degradation. 
As the field of antioxidant polymers emerges, important questions like the choice of 
antioxidant and the rate at which antioxidants should be released from the polymer still 
need to be addressed. The answers to these questions will likely depend on the settings in 
which the antioxidant polymers are intended to be used. For example, acute oxidative 
stress injury like ischemia-repurfusion requires form of antioxidant polymer suitable for 
vascular delivery (nanoparticles) that releases antioxidants gradually over a short period 
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of time (few hours to days). Whereas chronic disorders like non-healing wounds or 
biomaterial-induced local inflammation require antioxidant polymers in form of 
scaffolds/films/coatings that release antioxidants locally over a period of few weeks to 
months. In order to address these questions, there is a strong need for a flexible polymer 
chemistry platform that can allow for studying the biological response to a biomaterial 
based upon the type of antioxidant, the release rate and method of exposure (e.g., coating, 
nanoparticle, implant). 
 Poly(β-amino esters) (PBAE), synthesized by a conjugate addition reaction of 
primary/secondary amines with diacrylates, are a class of biodegradable polymers and 
hydrogels that have hydrolytically cleavable ester groups and a strong pH-dependent 
degradation rate that has been used for triggered drug/protein release [310-319]. Several 
research groups have studied vast libraries of acrylate and amine monomers to tune 
mechanical and degradation properties of PBAE [320, 321]. Much of this work focused 
on PBAE hydrogels involving a two-step synthesis method: i.) synthesis of a PBAE 
macromer/oligomer with acrylate end groups, followed by ii.) free radical polymerization 
of PBAE macromers/oligomers to form a crosslinked PBAE hydrogel. PBAE hydrogels 
provide a platform whereby appropriate choice of acrylate monomer, amine monomer 
and the ratio of two monomers, hydrogel properties can be tuned and their effect on tissue 
engineering and biomaterial applications can be studied [315, 322]. However, the second 
step of free radical polymerization, which requires use of free radical initiators and 
accelerators, can cause cellular toxicity during in situ polymerization [323]. Further, due 
to the highly reactive nature of free radicals, free radical polymerization can often be 
inhibited in the presence of cosolutes (e.g. drugs, porogens, etc.) resulting in poor gel 
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formation [324, 325]. Moreover, we have observed in our lab that free radical 
polymerization in the presence of antioxidants (e.g. green tea extracts, vitamin E, etc.) 
does not result in crosslinked hydrogels, due to the free radical inhibiting effects of these 
antioxidants.      
In this chapter, a modified non-free-radical polymerization poly(β-amino ester) 
chemistry [326] is presented as a platform to synthesize antioxidant polymers with 
tunable properties. Reaction kinetics of PBAE synthesis along with effect of different 
monomers and the ratio of acrylates to amines on the degradation of PBAE have been 
studied in detail by Biswal et. al. [326]. In the same study, Dipti Biswal had carried out 
the experiments to study swelling of PBAE in different organic solvents and found that 
PBAE hydrogels undergo degradation in primary alcohols. My contribution to this 
research article was to apply the polymer-solvent interaction parameters to understand 
swelling behavior of PBAE hydrogels in different organic solvents. Also, to understand 
the ethanol-based degradation mechanism, I characterized the PBAE degradation 
products using FTIR and taking advantage of this particular characteristic, PBAE was 
conjugated with ascorbic acid post-synthesis.  
6.2 Materials and Methods 
6.2.1 Materials 
Poly(ethylene glycol) 400 diacrylate (PEG400DA) and diethylene glycol 
diacrylate (DEGDA) were purchased from Polysciences, Inc. Three primary diamines, 
4,7,10-Trioxa-1,13-tridecane diamine (TTD), 2,2’ (ethylenedioxy) bis ethylamine 
(EDBE), and Hexamethyldiamine (HMD) were obtained from Sigma Aldrich. Quercetin, 
curcumin, acryloyl chloride, triethylamine and 2,2’-azo-bis(2-aminopropane)-HCl 
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(AAPH) were all purchased from Sigma-Aldrich. 2’,7’-dichlorodihydrofluorescein 
diacetate (DCF-DA) was purchased from Invitrogen. All organic solvents were obtained 
from Sigma-Aldrich and Fisher Scientific and used as received.  
6.2.2 Synthesis of PBAE 
PBAE hydrogels were synthesized by reacting a diacrylate and a primary diamine 
at 50oC by a one step Michael addition reaction. In a typical experiment, the desired 
amount of diacrylate (PEG400DA and DEGDA) was mixed with THF solvent (50wt% 
with respect to total monomer). The primary diamine (TTD, EDBE and HMD) was added 
to this solution at a set molar ratio to the total diacrylate content.  Next, the solution was 
transferred to a glass plate assembly, and the synthesis was carried out overnight in an 
oven at 50oC. After reaction, the gels were washed in THF and dried. Different grades of 
PBAE hydrogels prepared by varying the molar ratio of total acrylate to amine reactive 
groups (RTAA) from 0.25 to 1.65 are reported in Table 6-1 [1 mole of diacrylate 
corresponds to 2 moles of acrylate reactive groups; 1 mole of primary diamine 
corresponds to total 4 moles of primary/secondary amine reactive groups].  
6.2.3 Swelling Response of PBAE 
The swelling properties of the resultant hydrogels were evaluated using dimethyl 
sulfoxide (DMSO), tetrahydrofuran (THF), dichloromethane (DCM) and ethyl acetate 
(EtOAc) at room temperature. The initial mass of the hydrogel discs were recorded (Wo), 
and then, the discs were placed in the corresponding solvents at room temperature. The 
discs were removed from the solvents at a given time, and their masses were recorded in 
swollen state (Ws). The same solvents were used throughout the swelling studies. The  
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Table 6-1. List of PBAE Hydrogels Synthesized at Varying RTAA. 
Diacrylate Diamine RTAA 
PEG400DA TTD 0.6 
PEG400DA EDBE 0.6 
PEG400DA HMD 0.6 
PEG400DA TTD 1.2 
PEG400DA TTD 1.65 
DEGDA HMD 0.6 
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swelling state of the gel was then characterized by mass swelling ratio as explained before [327]. 
6.2.4 Calculations for Polymer-Solvent Interaction Parameter 
Polymer-solvent interaction parameter was calculated as described by Brandrup 
and is a sum of enthalpic (χH) and entropic (χS) components (Equation 1) [328]. χH is 
related to the Hildebrand solubility parameter (δ) and χS was considered to be constant at 
0.34 (Equation 2). In Equation 2, Vs is molar volume of the solvent and δS and δP are 
solubility parameter values for solvent and polymer respectively. 
 
                  
   
Solubility parameters and the molar volumes of the solvents were obtained from 
Brandrup and are tabulated in Table 6-2, while values for polymers were calculated using 
the group contribution method as described by Brandrup et. al., where solubility 
parameter is the square root of cohesive energy density (Equation 3) [328, 329]. Values 
for cohesive energy and molar volume of different groups for polymers  were obtained 
and are tabulated in Table 6-3 [329]. 
                                                                                              
 
 
 
 
 
34.0)( 2 +−= PSSRT
V δδχ (2) 
SH χχχ += (1) 
2/1)(
∑
∑=
i
i
polymer Vm
Ecoh
δ (3) 
 114 
 
Table 6-2. Solubility Parameter Values of the Solvents. 
Solvents Solubility Parameter (δ)   
[(Cal/cm3)1/2] 
Molar Volume (Vm)  
(cm3/mol) 
DMSO 12.0 71.3 
DCM 9.7 63.9 
THF 9.1 79.9 
EtOAc 9.1 98.5 
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Table 6-3. Group Contributions of Ecoh and Vm [329] 
Group 
Ecohi (J/mol) 
Vmi (cm3/mol) Hayes Hoftyzer and Van Krevelen Fedors 
-CH2- 4150 4190 4940 16.1 
-O- 6830 6290 3350 3.8 
-COO- 14160 3410 18000 18 
-NH- - - 8370 4.5 
-N<  -  - 4190 -9 
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6.2.5 FTIR Characterization of PBAE Degradation in Ethanol 
PBAE hydrogels (PEG400DA-TTD, RTAA=0.6) were degraded completely in 
water and ethanol. Viscous liquid degradation products were isolated by removing 
solvents through vacuum drying. FTIR measurements of dry degradation products were 
obtained using a Digilab Stingray system consisting of a FTIR 7000e stepscan 
spectrometer (Varian Inc.).   
6.2.6 Conjugation of PBAE Hydrogels with Ascorbic Acid 
Prior to conjugation with ascorbic acid, PBAE hydrogels (~ 80 mg) (PEG400DA-
TTD, RTAA=1.2) were swollen overnight in DMSO. Swollen PBAE hydrogels were 
then transferred to 3 ml of 26.6 mg/ml ascorbic acid solution in DMSO and incubated at 
37 0C for 48 hrs. Final ratio of ascorbic acid added for conjugation was 100 wt% with 
respect to PBAE hydrogel. To remove the unconjugated ascorbic acid, hydrogels were 
incubated in 10 ml of blank DMSO for 12 hrs and this procedure was repeated two more 
times. Hydrogels were then washed with THF to remove DMSO. Hydrogels were then 
subjected to vacuum to remove residual solvents and to result ascorbic acid-conjugated 
PBAE (AA-PBAE). 
6.2.7 Release of ascorbic acid from PBAE hydrogels 
AA-PBAE were incubated in 10 ml of PBS at 37 0C. 1 ml of supernatant was 
removed at every time point. To prevent ascorbic acid oxidation in water, samples were 
frozen as soon as they were collected. Samples were analyzed using a Shimadzu 
Prominence LC-20 AB HPLC system installed with a dual-wavelength UV detector. 95:5 
acetonitrile:H2O (with 1% TFA) was used as a eluent with a 4.6 X 150 mm Luna C18 
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column (Phenomenex, Torrance, CA). Ascorbic acid was monitored at a wavelength of 
256 nm. 
6.3 Results and Discussions  
6.3.1 PBAE Hydrogel Synthesis 
 As each primary amine is capable of reacting with two acrylate groups, a diamine 
has tetra-functionality, potentially permitting the synthesis of a crosslinked polymer 
network (Figure 6-1). Since PBAE undergo hydrolytic degradation, to synthesize 
hydrogels with varying network properties (hydrophilicity, rate of degradation and 
mechanical properties), two different diacrylates (with different length of PEG units) and 
three primary diamines (with varying hydrophilicity) were selected to study effect of 
monomers on PBAE properties.. In order to study effect of RTAA on hydrogel synthesis, 
the RTAA was varied from excess amine regime to excess acrylate regime, in range of 
0.25 to 1.65. 
 FTIR characterization of PBAE hydrogels and the effect of different monomers 
and RTAA on the degradation rate and mechanical properties of PBAE are discussed in 
detail by Biswal et. al. [326].  
6.3.2 Swelling Response 
 The swelling properties of the PBAE hydrogels with RTAA of 0.6 were analyzed. 
The hydrogels were swollen in DMSO, THF, DCM and EtOAc, in order to study the 
polymer-solvent interaction. The degree of swelling in different solvents for PEG400DA 
and DEGDA systems are presented in Figure 6-2. It has been observed that for all the 
systems in THF, DCM and EtOAc maximum swelling is achieved in approximately 2 hrs. 
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Figure 6-1. Reaction Schematic of PBAE Hydrogel Synthesis Using PEG400DA 
and HMD. 
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Figure 6-2. Swelling Response of Different Hydrogel Systems. 
Swelling response of PBAE hydrogels in (A) DMSO, (B) THF, (C) DCM, 
and (D) EtOAc; (E) image of PEG400DA-TTD (RTAA of 0.6) swollen 
gels in different solvents, (1) dry gel, (2) in DMSO, (3) in THF, (4) in 
DCM, and (5) in EtOAc. 
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However, in the case of DMSO as solvent, maximum swelling was observed in 
approximately 6 hrs. For all the systems, a greater degree of swelling was observed in 
DCM in comparison to the other solvents. 
This dependence of the extent of swelling on the polymer/solvent system could be 
explained by polymer-solvent interaction parameter, which is an indicator of polymer 
miscibility in the solvent.  Similar values of polymer and solvent solubility parameters 
result in χ < 0.5, which is the Flory-Huggins theory criterion for polymer miscibility in 
the solvent over the entire concentration range. The solubility parameter (δP) depends on 
polymer molecular structure, and the predicted δP values for some of the possible 
polymeric molecular structures are tabulated in Table 6-4. These polymer solubility 
parameter values were used to determine the polymer-solvent interaction parameter (χ) 
using equation 2. Depending on the RTAA used, PBAE networks can have some 
unreacted (residual) secondary amines (Figure 6-3A) or completely reacted tertiary 
amines (Figure 6-3B). Swelling studies were carried out for PBAE gels with RTAA=0.6, 
FTIR analysis of which indicates presence of unreacted (residual) secondary amines in 
the PBAE gel [326].  
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Table 6-4. Solubility Parameters for Different PBAE Polymer Networks. 
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a 
PEG400DA-TTD 11 1 30 2 0 0 219790 549.3 9.78 
PEG400DA-EDBE 10 1 26 2 0 0 196680 481.1 9.88 
PEG400DA-HMD 8 1 26 2 0 0 189980 473.5 9.79 
DEGDA-TTD 4 1 16 2 0 0 127180 297.3 10.11 
DEGDA-EDBE 3 1 12 2 0 0 104070 229.1 10.42 
DEGDA-HMD 1 1 12 2 0 0 97370 221.5 10.25 
Fi
gu
re
 6
-4
b 
PEG400DA-TTD 39 8 90 0 2 0 727630 1734.2 10.01 
PEG400DA-EDBE 38 8 86 0 2 0 704520 1666 10.05 
PEG400DA-HMD 36 8 86 0 2 0 697820 1658.4 10.03 
DEGDA-TTD 11 8 34 0 2 0 357190 726.2 10.84 
DEGDA-EDBE 10 8 30 0 2 0 334080 658 11.02 
DEGDA-HMD 8 8 30 0 2 0 327380 650.4 10.97 
Fi
gu
re
 6
-4
c 
PEG400DA-TTD 19 4 52 0 2 2 410330 1041.4 9.70 
PEG400DA-EDBE 18 4 48 0 2 2 387220 973.2 9.75 
PEG400DA-HMD 16 4 48 0 2 2 380520 965.6 9.70 
DEGDA-TTD 5 4 24 0 2 2 225110 537.4 10.01 
DEGDA-EDBE 4 4 20 0 2 2 202000 469.2 10.14 
DEGDA-HMD 2 4 20 0 2 2 195300 461.6 10.06 
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Figure 6-3. Hypothetical Structures for Different Possible PBAE Network.  
PBAE network (A) with unreacted secondary diamines, (B) where all the 
amines are reacted and (C) where secondary amines are capped with an 
hypothetical ethyl group. 
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Ideally, equilibrium swelling is inversely proportional to the χ value, where 
swelling is higher at lower χ. As observed in (Figure 6-4A and 6-4B), the degree of 
swelling for PBAE gels occurred in the order DCM>THF>EtOAc, which can be 
explained by lower χ values for PBAE-DCM system as compared to PBAE-THF<PBAE-
EtOAc. Also, hydrogels synthesized from PEG400DA swell to a greater extent than the 
corresponding hydrogels made from DEGDA, which can again be explained by lower χ 
values for PEG400DA based PBAE systems. Swelling, as described by the Flory-Rehner 
equation, is also a function of Mc (molecular weight between the crosslinks). The higher 
Mc in case of PEG400DA could also explain increased swelling as compared to DEGDA 
based PBAE systems. According to the χ values calculated by Ozdemir et al., PEG has a 
lower solubility in DMSO as compared to THF [330]. The lower solubility of PEG in 
DMSO should have resulted in the least swelling of PEG-based PBAE in DMSO. 
However, it was observed that the swelling of PBAE gels in DMSO is comparable to the 
swelling observed in THF and EtOAc. Predictions of polymer-solvent interaction 
parameter could deviate in case of polar solvents or polar polymer networks [329]. The 
highly polar nature of DMSO and its interaction with PEG in the PBAE network could be 
the reason for the failure to predict χ accurately in case of PBAE-DMSO system. 
In order to test the hypothesis that in case of the solvents studied here (DCM, 
THF, EtOAc and DMSO), PBAE-solvent interaction is mainly determined by PEG 
density in the PBAE network and not by the presence of secondary/tertiary amines in the 
network, χ values for a hypothetical polymer network (Figure 6-3C) were calculated 
where secondary amines in the Figure 6-3A were ethyl-capped. As shown in Figure 6-
4A and 6-4C, χ values for PBAE-solvent systems did not change significantly after  
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Figure 6-4. Correlation Between Equilibrium Swelling and χ for Corresponding 
Networks shown in Figure 6-3 (A-C).  
 
Solid markers -PEG400DA systems  
Empty markers-DEGDA systems 
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ethyl-capping secondary amines in the PBAE network. However, by increasing the PEG 
density in the PBAE network as shown in Figure 6-4B, χ values changed significantly 
for PEG400DA systems which indicates that χ depends mainly on PEG density in the 
network. 
6.3.3 FTIR Characterization of PBAE Degradation in Ethanol 
 While studying the swelling of PBAE in different solvents, it was observed that 
PBAE degraded in ethanol. To explore the degradation of PBAE in alcohols, effect of 
different alcohols (methanol, ethanol, 1-octanol, t-butanol), monomers and RTAA on the 
rate of PBAE degradation in alcohol were studied in detail [331]. In order to understand 
the mechanism of PBAE degradation in alcohol, degradation products of PBAE 
(PEG400DA-TTD, RTAA=1.2) in ethanol were characterized using FTIR (Figure 6-5). 
It has been reported previously that PBAE hydrogels degraded via hydrolysis of ester 
groups in the crosslinks to lower molecular weight degradation products and kinetic 
chains of poly(β-amino acids) and diols [321, 332]. The presence of a broad acid peak at 
1584 cm-1 in the water degradation products of PBAE with decrease of intensity of ester-
C=O peak at 1730 cm-1 clearly indicates the formation of low molecular weight acids. 
The transesterification reaction of PBAE with alcohols was also confirmed by the 
formation of new ester peaks at around 1732cm-1 from the ethanol degradation products 
of PBAE indicates that the degradation occurs via transesterification reaction of ethanol 
with β-amino ester bonds in PBAE network. The new ester products which were formed 
during the reaction of ethanol with the PBAE hydrogels, undergo further hydrolysis to 
form the corresponding acids. The decrease in the intensity of the ester peak at 1732cm-1  
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Figure 6-5. FTIR Characterization of PBAE Degradation in Ethanol (EtOH).  
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and formation of a new peak at around 1584cm-1 clearly indicates the hydrolysis of the 
new ester to the corresponding acid. 
6.3.4 Conjugation of PBAE with Ascorbic Acid and Controlled Release of 
Ascorbic Acid from AA-PBAE 
Ascorbic acid (Vitamin C) is a naturally occurring antioxidant and has primary 
and secondary alcohol groups in the molecular structure (Figure 6-6). Taking advantage 
of alcohol induced transesterification reaction in PBAE network, ascorbic acid was 
conjugated to the PBAE network. Extent of ascorbic acid conjugation in AA-PBAE could 
not be analyzed using FT-IR because of the overlapping of characteristic peak of 
aromatic -C=C- in ascorbic acid.  
However, release of ascorbic acid as a function of AA-PBAE degradation was 
studied. As shown in Figure 6-7, ascorbic acid was released gradually over a period of 3 
hrs.  At the end of AA-PBAE degradation, 3 mg of ascorbic acid was released as 
analyzed by HPLC. This corresponds to ~3.5 wt% of ascorbic acid loading in AA-PBAE. 
It was also observed that AA-PBAE degrades slower (~150 min) than corresponding 
PBAE (PEG400DA-TTD, RTAA=1.2) which degrades completely within 45 mins. The 
reason for slower degradation rate of AA-PBAE needs to be investigated further.  
Successful conjugation to ascorbic acid to PBAE provides PBAE as a means of 
controlled release for drugs with primary alcohol functional groups. 
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Figure 6-6. Molecular Structure of Ascorbic Acid 
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Figure 6-7. Ascorbic Acid Release from AA-PBAE 
AA-PBAE were incubated in PBS at 37 0C and ascorbic acid released in 
the supernatant was analyzed using HPLC. 
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6.4 Conclusions 
 A simple one-step method was developed to synthesize biodegradable PBAE with 
tunable properties. Theoretical analysis of PBAE swelling proved that swelling is 
dependent on the PEG density in the PBAE network. Ability of alcohols to degrade 
PBAE gels was successfully used to conjugate ascorbic acid to PBAE gels which upon 
degradation in water resulted in controlled release of ascorbic acid.  
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Chapter 7. Synthesis and Characterization of Poly(antioxidant β-amino esters) 
for Controlled Release of Polyphenolic Antioxidants 
Based on the research article to be submitted to: 
P.P. Wattamwar
7.1 Introduction 
, D. Biswal, A. Lyvers, D. Cochran, J.Z. Hilt and T.D. 
Dziubla, “Synthesis and Characterization of Poly(antioxidant β-amino 
esters) for Controlled Release of Polyphenolic Antioxidants”, Acta 
Biomaterialia (to be Submitted) 
 The non-free-radical polymerization poly(β-amino ester) chemistry described in 
the previous chapter provides a platform to develop and study antioxidant polymers with 
tunable properties. One of the important advantages of this chemistry is that it can be 
extended to all polyphenolic antioxidants thereby broadening the scope and properties of 
antioxidant polymers. In this work, we have synthesized poly(antioxidant β-amino ester) 
(PABAE) biodegradable hydrogels of two polyphenolic antioxidants, quercetin and 
curcumin. Acrylate functionalized antioxidants, quercetin multiacrylate (QMA) and 
curcumin multiacrylate (CMA) were synthesized and reacted with commercially 
available diacrylate and primary diamine monomer to result in a cross-linked network of 
PABAE. Degradation rate of PABAE was dependant on content of the hydrophobic 
antioxidant monomer and can be controlled by appropriate choice of commercially 
available monomers. PABAE degradation products possessed antioxidant activity and 
suppressed background oxidative stress levels in the cells, both in absence and presence 
of injury agent.   
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7.2 Materials and methods 
7.2.1 Materials 
Quercetin, curcumin, acryloyl chloride, 4,7,10-Trioxa-1,13-tridecanediamine 
(TTD), methylthiazolyldiphenyl-tetrazolium bromide (MTT), triethylamine, 2,2’-azo-
bis(2-aminopropane)-HCl (AAPH) and hydrogen peroxide (H2O2) were all purchased 
from Sigma-Aldrich. Poly(ethylene glycol) diacrylate (PEG400DA) was purchased from 
Polysciences, Inc. 2’,7’-dichlorodihydrofluorescein diacetate (DCF-DA) was purchased 
from Invitrogen. All organic solvents were obtained from Sigma-Aldrich and Fisher 
Scientific and used as received.  
7.2.2 Synthesis of Antioxidant Multiacrylates 
Antioxidant multiacrylates were synthesized by reacting phenolic antioxidants 
with acryoyl chloride in tetrahydrofuran (THF) and triethylamine at room temperature for 
12 hrs as previously described by Boudreaux et. al. [333] Antioxidants (quercetin or 
curcumin) were dissolved in THF at a concentration of 100 mg/ml. Triethylamine (Et3N) 
was added to the solution at an Et3N:antioxidant ratio of 4:1 and 2:1 for quercetin and 
curcumin, respectively. Acryloyl chloride was slowly added to the reaction mixture while 
being stirred on an ice bath. Initial molar ratio of acryoyl chloride:antioxidant was 4.5:1 
and 2.5:1 for quercetin and curcumin, respectively. The reaction was then allowed to 
proceed at room temperature under dark conditions for 12 hrs. After this reaction, 
precipitated triethylamine hydrochloride salt was removed by vacuum filtration. Filtrate 
was subject to vacuum distillation using liquid N2 trap to remove THF. To remove 
unreacted acryoyl chloride from the product, the resultant powder was re-dissolved in 
dichloromethane (DCM) (30 ml) and subsequently extracted with 0.1 M K2CO3 (3 X 
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120 ml) and DI water (3 X 120 ml), and then dried over MgSO4. Solution was filtered 
using vacuum filtration and solvent was removed under vacuum using a roto-evaporator 
(Rotovapor R II, Buchi, Switzerland). Synthesized antioxidant multiacrylates were 
characterized using FT-IR and 1H-NMR spectroscopy. The resulting powder was stored 
at -20 0C until further use.        
7.2.3 Synthesis of Poly(antioxidant β-amino esters) Hydrogels (PABAE) 
PABAE hydrogels were synthesized by a single step addition of acrylates 
(PEG400DA and antioxidant multiacrylates) and a primary diamine, TTD, as previously 
described [326]. Figure 1 shows a schematic of the crosslinked network in PABAE 
hydrogels.  Briefly, calculated amounts of PEG400DA and primary diamine TTD were 
mixed in a 2 ml eppendorf tube. This mixture was incubated at 50 0C for 5 min. 
Calculated amount of antioxidant multiacrylate dissolved in DCM solvent (50 wt% 
solvent with respect to total monomer) was transferred to the PEG400DA/TTD reaction 
mixture, mixed thoroughly and then incubated in an oven at 50 0C for 24 hrs. PABAE 
with different antioxidant contents were synthesized and their compositions are listed in 
Tables 7-1 and 7-2. Synthesized hydrogels were then cut into 1 mm thick discs for 
degradation studies. All discs were washed in THF for 15 min to remove unreacted 
monomers and dried under vacuum. Different grades of PABAE hydrogels were prepared 
by varying the molar ratio of antioxidant multiacrylate:PEG400DA between 0 – 20 % 
while maintaining the ratio of total acrylates to total amines (RTAA) at 1.2.  
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Figure 7-1. A simplified schematic representing synthesis of antioxidant 
multiacrylates and cross-linked polymer network in PABAE 
hydrogels. 
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Table 7-1. Composition of the Synthesized Quercetin PABAE Hydrogels.  
Sample Name 
wt% mol% 
PEG400DA QMA TTD PEG400DA QMA TTD 
0 84.70 0.00 15.30 70.60 0.00 29.40 
5% QMA 79.78 4.28 15.93 66.09 3.48 30.43 
10% QMA 74.95 8.49 16.55 61.71 6.86 31.43 
20% QMA 65.53 16.71 17.76 53.33 13.33 33.33 
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Table 7-2. Composition of the Synthesized Curcumin PABAE Hydrogels. 
Sample Name 
wt% mol% 
PEG400DA CMA TTD PEG400DA CMA TTD 
0 84.70 0.00 15.30 70.60 0.00 29.40 
5% CMA 80.67 3.98 15.34 67.06 3.53 29.41 
10% CMA 76.63 7.98 15.39 63.53 7.06 29.41 
20% CMA 68.48 16.05 15.47 56.47 14.12 29.41 
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7.2.4 Degradation of PABAE Hydrogels 
Degradation studies of PABAE hydrogels were carried out in PBS at 370C (pH 
7.4). At given time points, each set of gels were removed from the PBS, flash frozen in 
liquid nitrogen and freeze dried in order to remove residual water. The fraction of mass 
remaining was calculated from the ratio of the recorded final dry mass (Wd) and initial 
(Wo) values. 
7.2.5 In Vitro Assay for Measuring Antioxidant Activity of PABAE Degradation 
Products 
Antioxidant activity of the PABAE degradation products was measured using a 
DCF fluorescence-based assay as described previously [256]. AAPH undergoes thermal 
degradation and was used to mimic the peroxyl radical formation in vivo. Hydrolysis of 
DCF-DA results in non-fluorescent DCF which was then diluted in PBS to a 
concentration of 10 µM. To a well in 96-well plate, 100 µL of sample (solution of 
PABAE degradation products in PBS) and 100 µL of 10 µM DCF solution was added. 
Fluorescence measurement was started when 20 µL of AAPH solution was added to the 
well-plate and DCF fluorescence kinetics was monitored for 4 hrs using a Varian Cary 
Eclipse fluorescence spectrophotometer (excitation at 502 nm, emission at 525 nm). 
Assay was calibrated using known concentrations of both quercetin and curcumin, and 
the antioxidant potential of the quercetin/curcumin PABAE degradation products was 
reported as molar active quercetin/curcumin equivalents. 
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7.2.6 Cell Line 
Human umbilical vein endothelial cells (HUVECs) were purchased from Lonza 
and cultured in EGM-2 media with 2% fetal bovine serum at 37 0C in humidified 
atmosphere of 5% CO2. HUVECs in passage 3 to 5 were used for all the studies.  
7.2.7 Measuring Oxidative Stress in the Cells After Exposure to PABAE 
Degradation Products 
PABAE hydrogels were incubated in sterile DI water at 37 0C for 48 hrs to allow 
for complete degradation. PABAE degradation products were then freeze dried and 
dissolved in DMSO at a concentration of 100 mg/ml. These concentrated DMSO 
solutions were then used to prepare fresh dilute solutions of PABAE degradation 
products in cell media. Cells were treated with these PABAE solutions for their 
cytotoxicity and their effect on cellular oxidative stress levels. To prepare quercetin and 
curcumin solutions, antioxidants were dissolved in DMSO at a concentration of 10 mg/ml 
and diluted in cell media. 
2’,7’-dichlorodihydrofluorescein (DCF) fluorescence was used as marker of 
oxidative stress in the cells as described previously [334]. HUVECs were seeded onto a 
96-well plate at a density of 35,000 cells/cm2 and incubated at 37 0C. After 24 hrs, cell 
media was replaced with 100 µL of treatment solution (PABAE degradation products) 
and 100 µL of 10 µM DCF-DA solution. Fluorescence was measured after another 24 hrs 
using a bottom-reading GENios Pro fluorescence spectrophotometer (Tecan, 
Switzerland) at excitation and emission wavelengths of 485 nm and 535 nm respectively. 
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7.2.8 Cytotoxicity of PABAE Degradation Products  
The MTT assay was used to measure cell viability after treating cells with 
PABAE degradation products. HUVECs were seeded onto a 96-well plate at a cell 
density of 35,000 cells/cm2 and 24 hrs later, cell media was replaced with treatment 
solutions. 24 hrs post treatment, treatment solution was removed, cells washed twice in 
PBS and 200 µL of 0.5 mg/ml MTT solution in cell media was then added to each well. 
96-well plate was then incubated at 37 0C for 12 hrs and cell media was gently removed 
from the wells. 100 µL of DMSO was added to each well to dissolve the formazan 
product. The absorbance intensity was recorded at 570 nm for formazan and at 690 for 
background using a Cary-50 Bio UV-Visible spectrophotometer equipped with a Cary 50 
MPR microplate reader (Varian, Santa Clara, CA).  
7.2.9 In Vitro Cell Protection Against Oxidative Stress Injury Induced by H2O2 
HUVECs seeded at a cell density of 35,000 cells/cm2 in a 96-well plate were 
treated with 100 µL of antioxidant or PABAE solution for 2 hrs prior to adding 100 µL of 
1 mM H2O2 solution (in cell media). Cells were exposed to antioxidants at different 
concentrations and a final H2O2 concentration of 500 µM. 24 hrs later, cell viability was 
measured using MTT assay as described above. 
7.3 Results  
7.3.1 Synthesis and Characterization of Antioxidant Multiacrylates 
Synthesis of antioxidant multiacrylates was verified using FT-IR and 1H-NMR 
(Figure 7-2 and Figure 7-3).  The peaks at 1740 and 1620 cm-1 in the FT-IR spectra of 
QMA and CMA (Figure 7-2) are characteristics of the resulting ester –C=O and –C=C- 
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bonds in the product. Conversion of antioxidant phenolic groups into ester was further 
confirmed using 1H-NMR spectroscopy, where the peaks corresponding to the phenolic –
OH in antioxidants (at 9.0 – 10.7 ppm for quercetin, at 9.6 ppm for curcumin) had 
reduced peak intensities in the NMR spectra of antioxidant multiacrylates. Also, peaks 
corresponding to –CH=CH2 (in the range of 6.75 to 6 ppm) were present in the spectra of 
antioxidant multiacrylates. Average number of acrylate groups per molecule of 
antioxidant was quantified using 1H-NMR spectroscopy. Analysis of 1H-NMR spectra 
revealed presence of 4.28 and 2.66 acrylate groups per molecule of quercetin and 
curcumin respectively.       
7.3.2 Synthesis of PABAE Hydrogels 
For all the PABAE hydrogel synthesis reactions, acrylates were used in slight 
excess as compared to amines with the RTAA maintained at 1.2. It was observed that rate 
of the reaction increased with increase in antioxidant content in the reaction mixture. The 
system with 20% QMA and CMA polymerized faster than the corresponding 10% and 
5% systems. In previous work, rate of polymerization for 0% PABAE was analyzed 
using FT-IR [326]. However, in case of antioxidant PABAE, rate of polymerization could 
not be analyzed using FT-IR because of the overlapping of characteristic peak of 
aromatic –C=C- in QMA and CMA with aliphatic C=C- peak. 
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Figure 7-2. FTIR Characterization of Antioxidant Multiacrylates.  
Quercetin and curcumin were functionalized with acrylate groups by 
reacting with acryoyl chloride. Presence of peak at ~ 1740 cm-1 in the 
spectra of QMA (top) and CMA (bottom), which is characteristic of ester 
carbonyl group, indicates successful acrylate functionalization of quercetin 
and curcumin. 
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Figure 7-3. 1H-NMR Characterization of Antioxidant Monomers. 
Reaction of antioxidant phenolic groups of with acryoyl chloride is 
confirmed by the absence of characteristic phenol peaks (9 – 11 ppm) in 
the QMA and CMA products. Analysis of QMA and CMA spectra reveal 
presence of 4.28 and 2.66 acrylate groups per molecule of quercetin and 
curcumin, respectively. 
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7.3.3 Degradation of PABAE Hydrogels 
Degradation of all PABAE hydrogels was studied in PBS (pH = 7.4) at 37 0C. 
Figure 7-4 shows degradation profiles for quercetin and curcumin PABAE hydrogels 
respectively. In both quercetin and curcumin PABAE systems, pH change associated 
with degradation was minimal where the pH of the suspension of the degradation 
products changed from 7.4 to 8 after complete degradation. Hydrogels that did not have 
antioxidants (0) degraded quickly, within 150 mins, as compared to the quercetin and 
curcumin PABAE hydrogels that degraded completely within 5-6 hrs. Except for 20% 
CMA hydrogels, there was not a significant dose dependent effect of polyphenolic 
content on the hydrogel degradation rate. 
7.3.4 In Vitro Measurement of Antioxidant Activity of PABAE Degradation 
Products 
Antioxidant activity of PABAE degradation products was further verified using 
another in vitro assay where the DCF fluorescence was again used as a marker of 
oxidation by free radicals. Total antioxidant activity of quercetin PABAE hydrogels was 
directly proportional to the initial QMA content in the hydrogel with ~60% recovery as 
compared to the theoretical activity (Figure 7-5). In case of curcumin PABAE hydrogels, 
recovery of antioxidant activity was lower as compared to quercetin PABAE. 
Degradation of 5% CMA resulted in 40% recovery of antioxidant activity where as 
degradation of 10% CMA and 20% CMA resulted in 20% recovery of antioxidant 
activity. 
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Figure 7-4. Degradation Profiles of Quercetin (left) and Curcumin (right) 
PABAE. 
 
Quercetin (left) and curcumin (right) PABAE hydrogels degraded slower 
(within 250-350 mins) as compared to the fast degrading 0% PABAE 
hydrogel (in ~ 150 mins). 
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Figure 7-5. In Vitro Measurement of Antioxidant Activity of PABAE Degradation 
Products Using a DCF-based Fluorescent Assay. 
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7.3.5 Cytotoxicity of Degradation Products of PABAE Hydrogels 
HUVECs were treated with degradation products of PABAE at different 
concentrations for 24 hrs and the cell viability was measured using a standard MTT assay 
(Figure 7-6A and 7-6B). Degradation products of 0% PABAE hydrogel had very little 
cytotoxicity up to a concentration of 1000 µg/ml. Like quercetin, degradation products of 
quercetin PABAE hydrogels did not have significant cytotoxicity except for high 
concentrations of 20% QMA where the cell viability dropped to 35% at a concentration 
of 1000 µg/ml. Curcumin PABAE hydrogels, like pure curcumin, were acutely toxic in 
proportion to their curcumin content. 
7.3.6 Effect of PABAE Degradation Products on Oxidative Stress Levels in the 
Cells 
HUVECs were treated with degradation products of PABAE hydrogels in the 
presence of DCF for 24 hrs and DCF fluorescence was then measured. In Figure 7-7A 
and 7-7B, DCF fluorescence in the cells is plotted compared to the untreated cells (% of 
Control). Both antioxidants querectin and curcumin have excitation and emission spectra 
similar to that of DCF and in order to avoid background fluorescence from antioxidants, 
the maximum concentration of PABAE degradation products that HUVECs were treated 
with was limited to 100 µg/ml. Degradation products of 0% PABAE did not affect DCF 
146luorescence levels in HUVECs and did not exert antioxidant effect on the cells. 
However, quercetin and curcumin PABAE degradation products showed concentration 
dependant suppression in DCF fluorescence. At concentration of 100 µg/ml, querectin 
and curcumin PABAE hydrogels suppressed DCF fluorescence to a minimum of 35% 
and 55%, respectively.  
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Figure 7-6. Cytotoxicity of PABAE Degradation Products. 
(A and B) HUVECs were treated with PABAE degradation products for 
24 hrs and post treatment, cell viability was measured using MTT assay. 
0% PABAE hydrogels had did not have significant cytotoxicity. 
  
(C and D) Data in A and B was re-plotted with respect to theoretical 
antioxidant content of PABAE degradation products and it shows that 
cytotoxicity of PABAE degradation products is a function of its 
antioxidant content. Curcumin PABAE degradation products had 
cytotoxicity similar to that of free curcumin. 
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Figure 7-7. Effect of PABAE Degradation Products on Background Oxidative 
Stress in HUVECs. 
 
(A and B) Treatment of HUVECs with quercetin and curcumin PABAE 
degradation products suppressed background oxidative stress levels in the 
cells in a concentration dependant manner.  
(C and D) Data in A and B is re-plotted with respect to theoretical 
antioxidant content of PABAE degradation products. 
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7.3.7 H2O2 Induced Oxidative Stress Injury and Protection from PABAE 
Degradation Products  
In this prophylactic study, HUVECs were treated with antioxidants or PABAE 
degradation products prior to adding H2O2 to induce the oxidative stress in cells. Cell 
viability, measured using MTT assay 24 hrs post treatment, was used as a measure of 
extent of injury to cells. As shown in Figure 7-8, treatment of HUVECs with H2O2 only 
resulted in a drop in cell viability to 70%. Pre-treatment of cells with quercetin and 10% 
QMA degradation product did not result in a drop in viability. However, pre-treatment 
with curcumin resulted in further decrease in cell viability to 57%. 10% CMA treatment 
provided modest protection with cell viability of 80%. 
7.4 Discussion 
In the present work, a modified poly(β-amino ester) chemistry [326] was used to 
successfully synthesize hydrolytically degradable cross-linked polymers for controlled 
release of polyphenolic antioxidants quercetin and curcumin. Some of the advantages of 
this poly(β-amino ester) chemistry are i.) it does not require free-radical polymerization, 
thereby allowing loading of antioxidant drugs that are susceptible to free-radical damage, 
ii.) the large libraries of commercial diacrylates [320, 321]  could be used to tune 
polymer properties (e.g. degradation rate, mechanical strength, etc.) and iii.) it could be 
extended to other polyphenolic antioxidants. 
Synthesized QMA and CMA were characterized using FT-IR and 1H-NMR 
spectroscopy. Acrylate functionalization of phenol groups in the antioxidants was 
verified by both FT-IR and 1H-NMR. QMA and CMA were synthesized with initial ratio 
of acryloyl chloride to quercetin at 4.5 and acryoyl chloride to curcumin ratio at 2.5.  
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Figure 7-8. Cell Protection Against Oxidative Stress Injury by PABAE 
Degradation Products 
 
 HUVECs were treated with antioxidants or PABAE degradation products 
2 hrs prior to inducing oxidative stress injury by addition of H2O2. Cell 
viability was measured after 24 hrs using MTT assay. (M + SE). Groups 
were compared using Paired Student t-test. * indicates significant 
difference from control and # indicates significant difference from H2O2 
only treatment, with p<0.05. 
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Synthesis of QMA resulted in 4.28 acrylate groups per molecule of quercetin, lower than 
the targeted number of 4.5 acrylate groups per molecule of quercetin. However, analysis 
of 1H-NMR spectra of CMA revealed 2.66 acrylate groups per molecule of curcumin, 
which was higher than 2.5, the initial ratio of acryloyl chloride to curcumin during the 
synthesis of CMA. This could indicate presence of free acrylic acid impurity (byproduct 
of reaction of acryoyl chloride and water) remaining in the CMA product. Nonetheless, 
this slightly impure CMA was used for synthesis of PABAE hydrogels. Presence of 
unreacted phenol groups in the monomers (QMA and CMA) would have hindered 
hydrogel synthesis using the conventional free radical polymerization technique as a 
result of the radical scavenging ability of phenol groups. The Michael type addition 
chemistry used in this work to synthesize a crosslinked network overcomes this inability 
of free radical polymerization to incorporate phenolic compounds in polymer backbone. 
We have previously reported synthesis and degradation characteristics of poly(β-
amino ester) hydrogels that utilizes a Michael type addition reaction between 
multifunctional acrylates and tetrafunctional primarydiamines [326]. In this work, in 
addition to the commercial monomers PEG400DA and TTD, synthesized antioxidants 
multiacrylates were also used for PABAE hydrogel synthesis. As shown in Figure 4, 0% 
PABAE hydrogels degrade completely within 150 min. However, inclusion of as low as 
5% of relatively hydrophobic antioxidant multiacrylates slowed the degradation rate of 
PABAE hydrogels where they completely degraded in 250-350 mins. One of the several 
advantages of this poly(β-amino ester) chemistry is that it can be easily tuned to 
synthesize slower degrading PABAE hydrogels by controlling the ratio of hydrophilic 
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monomers (PEG400DA and TTD) to relatively hydrophobic monomers (e.g. 1,3-
butanediol diacrylate  and hexamethylene diamine). 
Quercetin is known to be a safe flavonol with relatively high IC50 values of 113 
µM for human normal liver cells L-02 [335]. However, in contrast to the previously 
reported 18.4 µg/ml (61 µM) IC50 value of quercetin for HUVECs, we did not observe 
any significant quercetin toxicity to HUVECs up to a concentration of 100 µg/ml [336]. 
IC50 concentrations of curcumin PABAE hydrogels decreased with increase in CMA 
content where 5% CMA, 10% CMA and 20% CMA had IC50 concentrations of 62.1, 10.2 
and 8.7 µg/ml. IC50 value of pure curcumin for HUVECs was found to be 6.8 µg/ml, 
which is similar to the previously reported value of 10.8 µg/ml [337]. When the data in 
Figure 6A and 6B is normalized with respect to antioxidant content in the PABAE 
hydrogels as shown in Figure 6C and 6D, the toxicity profiles of PABAE hydrogels are 
similar to that of pure antioxidants meaning that the toxicity of PABAE hydrogels is the 
result of their antioxidant content. This is particularly evident in case of curcumin 
PABAE hydrogels (Figure 6D) where all curcumin PABAE degradation products have an 
acute toxicity concentration of ~40 µg/ml curcumin equivalents.  
Despite limitations with its specificity for the exact oxidative species [306-309, 
334], DCF fluorescence is a commonly used marker to study oxidative stress in the cells 
and was applied to study effect of PABAE degradation products on oxidative stress levels 
in HUVECs. The model is based on the principle that DCF-DA (2’,7’-
dichlorodihydrofluorescein diacetate), a non-fluorescent ester form of the dye, is taken up 
by the cells and active esterases in the cells cleave it to a non-fluorescent product DCFH 
(2’,7’-dichlorodihydrofluorescein). Free radicals in the cells can then react with DCFH to 
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result in a fluorescent product DCF (2’,7’-dichlorofluorescein). When the data in Figure 
7A and 7B is normalized with respect to the antioxidant content of PABAE hydrogels as 
plotted in Figure 7C and 7D, it is evident that suppression of DCF fluorescence by 
PABAE degradation products is a result of antioxidant content in PABAE.  
H2O2 at submillimolar concentrations induce apoptosis in endothelial cells via 
redox dependant pathways [338]. It has been shown that several polyphenolic flavanoids 
including quercetin have antiapoptotic effect against H2O2 injury [339]. Treatment of 
HUVECs with 500 µM H2O2 for 24 hrs resulted in 30% cell death as measured by MTT 
assay. Previous studies have shown that treatment with 200 µM H2O2 can cause upto 
70% cell death. Reduced cell death at higher H2O2 concentration observed in this study 
could be a result of 2% serum based cell media used to prepare H2O2 solutions, where 
catalase or other enzymes present in the serum can detoxify some of the H2O2. 
Nonetheless, treatment of HUVECs with 500 µM caused significant toxicity as compared 
to controls. Pre-treatment of HUVECs with 5 µg/ml quercetin and 50 µg/ml of 10% 
QMA degradation product (5 µg/ml theoretical quercetin equivalents) protected cells 
from H2O2 injury, which confirms with results from other studies [339]. As shown in 
Figure 7-6D, treatment of HUVECs with 5 µg/ml curcumin alone results in 40% cell 
death. Pre-treatment of HUVECs with curcumin, ads to the H2O2 injury. Protection 
provided by 10% CDA degradation products was very modest and improved cell viability 
by less than 10%. 
7.5 Conclusions 
The single-step polymerization method for synthesis of poly(β-amino ester) 
hydrogels [326] was successfully applied for incorporating polyphenolic antioxidants in 
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to the PABAE network by acrylate functionalization of polyphenols. Cytotoxicity of 
PABAE degradation products was a function of both, the type of antioxidant used and % 
antioxidant content in PABAE, where quercetin PABAE had very little to no cytotoxicity 
and curcumin PABAE had cytotoxicity similar to that of pure curcumin. Also, 
degradation products of PABAE hydrogels possessed antioxidant activity. Treatment of 
HUVECs with PABAE degradation products suppressed background oxidative stress in 
the cells. PABAE developed in this work can be used for various drug delivery and tissue 
engineering applications where controlled delivery of polyphenolic antioxidants is 
desired. 
 
 
 
 
 
 
 
 
 
 
 155 
 
Chapter 8. Conclusions 
 
 In this work, three different antioxidant polymers were developed for controlled 
release of antioxidants to suppress oxidative stress. Initial studies involved synthesis and 
characterization of poly(trolox ester), which was formulated in to nanoparticles to 
determine its application as polymeric antioxidant carrier. In vitro degradation studies 
revealed that poly(trolox ester) is not hydrolytically degradable but undergoes enzymatic 
degradation to release degradation products that have antioxidant radical scavenging 
ability. Poly(trolox ester) nanoparticles do not have significant cytotoxicity and provided 
protection in an in vitro cell injury model where oxidative stress injury was induced by 
treating cells with metal nanoparticles. It was also observed that in absence of injury, 
poly(trolox ester) nanoparticles suppressed background oxidative stress in the cells. In 
order to explore this effect of poly(trolox ester), a detailed study was carried out to 
understand concentration dependant antioxidant and pro-oxidant effect of trolox and 
poly(trolox ester) nanoparticles. Poly(trolox ester) nanoparticles possessed a unique 
ability to suppress protein oxidation, a feature not seen in the free trolox form, 
emphasizing the advantage of delivery formulation upon regulating cellular responses. 
This study showed that poly(trolox ester) can be used to modulate cellular redox state, 
proving the concept of antioxidant polymers. 
 While the work on poly(trolox ester) is promising, it is limited by enzymatic 
degradation of polymer, not allowing significant control over its rate of degradation. 
Therefore, a hydrolytically degradable PABAE were synthesized. PABAE synthesis 
scheme is more robust and can be extended to all polyphenolic antioxidants while 
allowing control to tune the rate of polymer degradation. To demonstrate the flexibility of 
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PABAE synthesis scheme, quercetin and curcumin PABAE were synthesized and 
characterized. PABAE degradation products possessed antioxidant activity which was 
further confirmed by their ability to suppress oxidative stress in cells, both in absence and 
presence of injury agent. 
 Overall, this works shows the potential of antioxidant polymers to modulate 
cellular redox state by controlled release of antioxidants. This can have far reaching 
implications in field of biomaterials and in variety of biomedical, pharmaceutical and 
tissue engineering applications.  
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